Cervical cancer screening programme: annual statistics

Suomeksi

På Svenska

Screening programme overview

– The national cervical cancer screening programme has been running since the 1970s. In 2024 the screening method was either HPV-testing (92%) or Pap testing (8%) depending on the wellbeing services county.

– The target population, i.e., ages 30 to 65, were invited for routine screening at ages divisible by five. In some municipalities those aged 25 were also invited. In addition, those who had a mild positive screening result (HPV-positivity, ASC-US, LSIL) in the previous screening round and were not referred to further examinations, received an invitation for risk group screening.

– 280,812 persons were drawn from the Digital and Population Data Services Agency database for the screening invitation. An invitation may not be sent, for example due to a missing address resulting from a non-disclosure restriction.

– Out of the target population in 2024, 73% attended screening. In routine screening 5.6% were recommended risk group screening and 1.2% were referred for further examinations. In risk group screening 1.3% received a recommendation to another risk group screen and 44.2% were referred to further examinations.

– Based on the colposcopies performed as further examinations, altogether 43 cervical cancers and 1,448 severe precancers were detected.

Whole country

Screening process

2024

Age group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30	35723	23907	66.9	2457	10.3	662	2.8	565	85.3	262	46.4
35	36398	25406	69.8	1768	7.0	434	1.7	370	85.3	177	47.8
40	36653	26654	72.7	1526	5.7	374	1.4	314	84.0	133	42.4
45	34415	25958	75.4	1269	4.9	294	1.1	249	84.7	80	32.1
50	32313	24838	76.9	1224	4.9	225	0.9	192	85.3	53	27.6
55	32680	24907	76.2	1090	4.4	164	0.7	134	81.7	38	28.4
60	36807	27826	75.6	1110	4.0	152	0.5	132	86.8	25	18.9
65	35823	26841	74.9	1009	3.8	140	0.5	115	82.1	28	24.3
Total	280812	206337	73.5	11453	5.6	2445	1.2	2071	84.7	796	38.4

Risk group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30-34	2442	1942	79.5	18	0.9	994	51.2	841	84.6	223	26.5
35-39	1646	1311	79.6	16	1.2	596	45.5	504	84.6	126	25.0
40-44	1554	1255	80.8	22	1.8	576	45.9	502	87.2	139	27.7
45-49	1292	1048	81.1	17	1.6	421	40.2	355	84.3	74	20.8
50-54	1166	993	85.2	13	1.3	365	36.8	317	86.8	44	13.9
55-59	1197	1053	88.0	14	1.3	425	40.4	366	86.1	36	9.8
60-64	1102	948	86.0	10	1.1	417	44.0	345	82.7	31	9.0
65-69	899	791	88.0	13	1.6	338	42.7	287	84.9	22	7.7
Total	11298	9341	82.7	123	1.3	4132	44.2	3517	85.1	695	19.8

2023

Age group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30	35085	23063	65.7	2262	9.8	596	2.6	545	91.4	241	44.2
35	35710	24668	69.1	1681	6.8	438	1.8	407	92.9	195	47.9
40	36523	26551	72.7	1462	5.5	381	1.4	362	95.0	175	48.3
45	33924	25410	74.9	1313	5.2	298	1.2	271	90.9	104	38.4
50	29058	22381	77.0	1116	5.0	223	1.0	199	89.2	70	35.2
55	35104	26619	75.8	1191	4.5	200	0.8	173	86.5	44	25.4
60	37155	28063	75.5	1097	3.9	191	0.7	172	90.1	48	27.9
65	34808	26071	74.9	931	3.6	141	0.5	125	88.7	37	29.6
Total	277367	202826	73.1	11053	5.4	2468	1.2	2254	91.3	914	40.6

Risk group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30-34	2170	1745	80.4	17	1.0	874	50.1	763	87.3	234	30.7
35-39	1390	1098	79.0	14	1.3	537	48.9	468	87.2	150	32.1
40-44	1250	1007	80.6	10	1.0	437	43.4	379	86.7	123	32.5
45-49	1135	921	81.1	17	1.8	331	35.9	283	85.5	83	29.3
50-54	1102	933	84.7	13	1.4	363	38.9	320	88.2	38	11.9
55-59	1104	951	86.1	15	1.6	380	40.0	336	88.4	36	10.7
60-64	963	842	87.4	16	1.9	377	44.8	318	84.4	32	10.1
65-69	449	403	89.8	1	0.2	198	49.1	173	87.4	16	9.2
Total	9563	7900	82.6	103	1.3	3497	44.3	3040	86.9	712	23.4

2022

Age group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30	35821	22818	63.7	2295	10.1	467	2.0	453	97.0	228	50.3
35	33470	22638	67.6	1524	6.7	370	1.6	363	98.1	189	52.1
40	35724	25723	72.0	1509	5.9	353	1.4	342	96.9	167	48.8
45	34273	25436	74.2	1268	5.0	292	1.1	281	96.2	129	45.9
50	30100	22833	75.9	1164	5.1	201	0.9	191	95.0	57	29.8
55	36015	27228	75.6	1201	4.4	178	0.7	172	96.6	47	27.3
60	36879	27761	75.3	1095	3.9	142	0.5	136	95.8	31	22.8
65	36491	27304	74.8	888	3.3	114	0.4	112	98.2	28	25.0
Total	278773	201741	72.4	10944	5.4	2117	1.0	2050	96.8	876	42.7

Risk group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30-34	2528	1889	74.7	20	1.1	917	48.5	876	95.5	251	28.7
35-39	1713	1305	76.2	14	1.1	604	46.3	586	97.0	185	31.6
40-44	1385	1078	77.8	25	2.3	442	41.0	428	96.8	131	30.6
45-49	1260	988	78.4	27	2.7	378	38.3	368	97.4	92	25.0
50-54	1191	962	80.8	28	2.9	334	34.7	319	95.5	56	17.6
55-59	1201	999	83.2	32	3.2	350	35.0	334	95.4	36	10.8
60-64	1050	858	81.7	22	2.6	324	37.8	310	95.7	38	12.3
65-69	452	386	85.4	0	0.0	162	42.0	156	96.3	16	10.3
Total	10780	8465	78.5	168	2.0	3511	41.5	3377	96.2	805	23.8

2021

Age group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30	35045	22911	65.4	2461	10.7	540	2.4	502	93.0	255	50.8
35	33512	22995	68.6	1614	7.0	392	1.7	355	90.6	206	58.0
40	34329	25084	73.1	1425	5.7	305	1.2	281	92.1	149	53.0
45	34064	25488	74.8	1306	5.1	269	1.1	245	91.1	118	48.2
50	31245	23897	76.5	1207	5.1	196	0.8	183	93.4	60	32.8
55	36243	27470	75.8	1232	4.5	182	0.7	160	87.9	63	39.4
60	36791	27918	75.9	1036	3.7	118	0.4	101	85.6	38	37.6
65	15864	11674	73.6	441	3.8	42	0.4	38	90.5	11	28.9
Total	257093	187437	72.9	10722	5.7	2044	1.1	1865	91.2	900	48.3

Risk group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30-34	2158	1706	79.1	52	3.0	754	44.2	733	97.2	214	29.2
35-39	1770	1431	80.8	84	5.9	517	36.1	505	97.7	151	29.9
40-44	1547	1263	81.6	73	5.8	414	32.8	392	94.7	118	30.1
45-49	1454	1214	83.5	56	4.6	304	25.0	291	95.7	78	26.8
50-54	1475	1219	82.6	78	6.4	284	23.3	279	98.2	53	19.0
55-59	1269	1090	85.9	57	5.2	298	27.3	288	96.6	29	10.1
60-64	1150	976	84.9	69	7.1	312	32.0	296	94.9	25	8.4
65-69	461	391	84.8	15	3.8	133	34.0	121	91.0	12	9.9
Total	11284	9290	82.3	484	5.2	3016	32.5	2905	96.3	680	23.4

2020

Age group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30	35169	22240	63.2	2297	10.3	372	1.7	363	97.6	202	55.6
35	34331	22732	66.2	1489	6.6	315	1.4	312	99.0	172	55.1
40	33775	23823	70.5	1245	5.2	267	1.1	265	99.3	143	54.0
45	33213	23987	72.2	1142	4.8	200	0.8	199	99.5	95	47.7
50	32247	23996	74.4	1092	4.6	168	0.7	168	100.0	57	33.9
55	36443	26962	74.0	1118	4.1	147	0.5	147	100.0	57	38.8
60	36848	27365	74.3	982	3.6	127	0.5	126	99.2	48	38.1
65	15730	11278	71.7	397	3.5	33	0.3	33	100.0	6	18.2
Total	257756	182383	70.8	9762	5.4	1629	0.9	1613	99.0	780	48.4

Risk group screening

Age group	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
30-34	451	263	58.3	36	13.7	51	19.4	51	100.0	20	39.2
35-39	520	335	64.4	46	13.7	70	20.9	70	100.0	31	44.3
40-44	519	352	67.8	47	13.4	47	13.4	47	100.0	16	34.0
45-49	484	328	67.8	44	13.4	42	12.8	42	100.0	16	38.1
50-54	665	458	68.9	49	10.7	55	12.0	54	98.2	8	14.8
55-59	607	434	71.5	28	6.5	58	13.4	58	100.0	6	10.3
60-64	457	301	65.9	32	10.6	40	13.3	40	100.0	5	12.5
65-69	91	81	89.0	16	19.8	18	22.2	18	100.0	6	33.3
Total	3794	2552	67.3	298	11.7	381	14.9	380	99.7	108	28.4

Changes in participation rate

Screening results

Proportion of attended

2024

Age group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30	23907	662	2.8	2457	10.3	20782	86.9	6	0	20528	85.9	2929	14.3
35	25406	434	1.7	1768	7.0	23202	91.3	2	0	23705	93.3	2122	9.0
40	26654	374	1.4	1526	5.7	24750	92.9	4	0	24827	93.1	1778	7.2
45	25958	294	1.1	1269	4.9	24390	94.0	5	0	24127	92.9	1439	6.0
50	24838	225	0.9	1224	4.9	23385	94.2	4	0	23148	93.2	1321	5.7
55	24907	164	0.7	1090	4.4	23651	95.0	2	0	23267	93.4	1169	5.0
60	27826	152	0.5	1110	4.0	26556	95.4	8	0	25861	92.9	1180	4.6
65	26841	140	0.5	1009	3.8	25685	95.7	7	0	24827	92.5	1083	4.4
Total	206337	2445	1.2	11453	5.6	192401	93.2	38	0	190290	92.2	13021	6.8

Risk group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30-34	1942	994	51.2	18	0.9	929	47.8	1	0.1	1915	98.6	1005	52.5
35-39	1311	596	45.5	16	1.2	698	53.2	1	0.1	1280	97.6	602	47.0
40-44	1255	576	45.9	22	1.8	656	52.3	1	0.1	1194	95.1	589	49.3
45-49	1048	421	40.2	17	1.6	610	58.2	0	0.0	994	94.8	426	42.9
50-54	993	365	36.8	13	1.3	615	61.9	0	0.0	945	95.2	370	39.2
55-59	1053	425	40.4	14	1.3	614	58.3	0	0.0	1009	95.8	435	43.1
60-64	948	417	44.0	10	1.1	520	54.9	1	0.1	908	95.8	420	46.3
65-69	791	338	42.7	13	1.6	440	55.6	0	0.0	772	97.6	345	44.7
Total	9341	4132	44.2	123	1.3	5082	54.4	4	0.0	9017	96.5	4192	46.5

2023

Age group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30	23063	596	2.6	2262	9.8	20188	87.5	17	0.1	17923	77.7	2551	14.2
35	24668	438	1.8	1681	6.8	22538	91.4	11	0.0	20706	83.9	1893	9.1
40	26551	381	1.4	1462	5.5	24698	93.0	10	0.0	22074	83.1	1555	7.0
45	25410	298	1.2	1313	5.2	23790	93.6	9	0.0	21128	83.1	1307	6.2
50	22381	223	1.0	1116	5.0	21035	94.0	7	0.0	18658	83.4	1055	5.7
55	26619	200	0.8	1191	4.5	25222	94.8	6	0.0	22041	82.8	1170	5.3
60	28063	191	0.7	1097	3.9	26763	95.4	12	0.0	22833	81.4	1089	4.8
65	26071	141	0.5	931	3.6	24987	95.8	12	0.0	21034	80.7	911	4.3
Total	202826	2468	1.2	11053	5.4	189221	93.3	84	0.0	166397	82.0	11531	6.9

Risk group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30-34	1745	874	50.1	17	1.0	853	48.9	1	0.1	1671	95.8	878	52.5
35-39	1098	537	48.9	14	1.3	547	49.8	0	0.0	1006	91.6	527	52.4
40-44	1007	437	43.4	10	1.0	560	55.6	0	0.0	897	89.1	426	47.5
45-49	921	331	35.9	17	1.8	573	62.2	0	0.0	794	86.2	325	40.9
50-54	933	363	38.9	13	1.4	555	59.5	2	0.2	788	84.5	345	43.8
55-59	951	380	40.0	15	1.6	552	58.0	4	0.4	804	84.5	363	45.1
60-64	842	377	44.8	16	1.9	446	53.0	3	0.4	735	87.3	359	48.8
65-69	403	198	49.1	1	0.2	204	50.6	0	0.0	392	97.3	199	50.8
Total	7900	3497	44.3	103	1.3	4290	54.3	10	0.1	7087	89.7	3422	48.3

2022

Age group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30	22818	467	2.0	2295	10.1	20042	87.8	14	0.1	18499	81.1	2537	13.7
35	22638	370	1.6	1524	6.7	20733	91.6	11	0.0	17950	79.3	1636	9.1
40	25723	353	1.4	1509	5.9	23842	92.7	19	0.1	20107	78.2	1506	7.5
45	25436	292	1.1	1268	5.0	23859	93.8	17	0.1	19835	78.0	1216	6.1
50	22833	201	0.9	1164	5.1	21459	94.0	9	0.0	17586	77.0	1019	5.8
55	27228	178	0.7	1201	4.4	25835	94.9	14	0.1	20925	76.9	1053	5.0
60	27761	142	0.5	1095	3.9	26495	95.4	29	0.1	21206	76.4	985	4.6
65	27304	114	0.4	888	3.3	26265	96.2	37	0.1	20342	74.5	789	3.9
Total	201741	2117	1.0	10944	5.4	188530	93.5	150	0.1	156450	77.5	10741	6.9

Risk group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30-34	1889	917	48.5	20	1.1	952	50.4	0	0.0	1795	95.0	910	50.7
35-39	1305	604	46.3	14	1.1	685	52.5	2	0.2	1191	91.3	596	50.0
40-44	1078	442	41.0	25	2.3	611	56.7	0	0.0	926	85.9	429	46.3
45-49	988	378	38.3	27	2.7	582	58.9	1	0.1	833	84.3	361	43.3
50-54	962	334	34.7	28	2.9	599	62.3	1	0.1	796	82.7	321	40.3
55-59	999	350	35.0	32	3.2	617	61.8	0	0.0	845	84.6	337	39.9
60-64	858	324	37.8	22	2.6	510	59.4	2	0.2	746	86.9	317	42.5
65-69	386	162	42.0	0	0.0	224	58.0	0	0.0	376	97.4	159	42.3
Total	8465	3511	41.5	168	2.0	4780	56.5	6	0.1	7508	88.7	3430	45.7

2021

Age group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30	22911	540	2.4	2461	10.7	19883	86.8	27	0.1	17135	74.8	2717	15.9
35	22995	392	1.7	1614	7.0	20966	91.2	23	0.1	16598	72.2	1667	10.0
40	25084	305	1.2	1425	5.7	23336	93.0	18	0.1	17744	70.7	1311	7.4
45	25488	269	1.1	1306	5.1	23900	93.8	13	0.1	17886	70.2	1137	6.4
50	23897	196	0.8	1207	5.1	22483	94.1	11	0.0	16345	68.4	970	5.9
55	27470	182	0.7	1232	4.5	26038	94.8	18	0.1	18698	68.1	997	5.3
60	27918	118	0.4	1036	3.7	26738	95.8	26	0.1	18215	65.2	832	4.6
65	11674	42	0.4	441	3.8	11187	95.8	4	0.0	10224	87.6	446	4.4
Total	187437	2044	1.1	10722	5.7	174531	93.1	140	0.1	132845	70.9	10077	7.6

Risk group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30-34	1706	754	44.2	52	3.0	898	52.6	2	0.1	1577	92.4	766	48.6
35-39	1431	517	36.1	84	5.9	829	57.9	1	0.1	1272	88.9	565	44.4
40-44	1263	414	32.8	73	5.8	775	61.4	1	0.1	1067	84.5	444	41.6
45-49	1214	304	25.0	56	4.6	854	70.3	0	0.0	959	79.0	306	31.9
50-54	1219	284	23.3	78	6.4	855	70.1	2	0.2	965	79.2	308	31.9
55-59	1090	298	27.3	57	5.2	735	67.4	0	0.0	833	76.4	310	37.2
60-64	976	312	32.0	69	7.1	594	60.9	1	0.1	772	79.1	336	43.5
65-69	391	133	34.0	15	3.8	243	62.1	0	0.0	369	94.4	143	38.8
Total	9290	3016	32.5	484	5.2	5783	62.2	7	0.1	7814	84.1	3178	40.7

2020

Age group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30	22240	372	1.7	2297	10.3	19565	88.0	6	0	15262	68.6	2386	15.6
35	22732	315	1.4	1489	6.6	20926	92.1	2	0	15234	67.0	1509	9.9
40	23823	267	1.1	1245	5.2	22310	93.6	1	0	15500	65.1	1162	7.5
45	23987	200	0.8	1142	4.8	22642	94.4	3	0	15463	64.5	966	6.2
50	23996	168	0.7	1092	4.6	22735	94.7	1	0	15075	62.8	897	6.0
55	26962	147	0.5	1118	4.1	25697	95.3	0	0	16551	61.4	924	5.6
60	27365	127	0.5	982	3.6	26255	95.9	1	0	16206	59.2	824	5.1
65	11278	33	0.3	397	3.5	10845	96.2	3	0	8803	78.1	390	4.4
Total	182383	1629	0.9	9762	5.4	170975	93.7	17	0	118094	64.8	9058	7.7

Risk group screening

Age group	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
30-34	263	51	19.4	36	13.7	176	66.9	0	0	153	58.2	67	43.8
35-39	335	70	20.9	46	13.7	219	65.4	0	0	190	56.7	86	45.3
40-44	352	47	13.4	47	13.4	258	73.3	0	0	166	47.2	58	34.9
45-49	328	42	12.8	44	13.4	242	73.8	0	0	147	44.8	53	36.1
50-54	458	55	12.0	49	10.7	354	77.3	0	0	212	46.3	54	25.5
55-59	434	58	13.4	28	6.5	348	80.2	0	0	195	44.9	50	25.6
60-64	301	40	13.3	32	10.6	229	76.1	0	0	150	49.8	45	30.0
65-69	81	18	22.2	16	19.8	47	58.0	0	0	67	82.7	30	44.8
Total	2552	381	14.9	298	11.7	1873	73.4	0	0	1280	50.2	443	34.6

Changes in positivity rate

Test positives (ASC-US+/HPV)

Proportion of attended

Histological findings

Proportion of referred

2024

Age group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	1096	11	1.0	22	2.0	406	37.0	243	22.2	242	22.1	11	1.0	161	14.7
40-49	668	9	1.3	9	1.3	195	29.2	182	27.2	158	23.7	10	1.5	105	15.7
50-59	389	3	0.8	1	0.3	87	22.4	105	27.0	121	31.1	9	2.3	63	16.2
60-69	292	4	1.4	1	0.3	48	16.4	82	28.1	101	34.6	11	3.8	45	15.4
Total	2445	27	1.1	33	1.3	736	30.1	612	25.0	622	25.4	41	1.7	374	15.3

Risk group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	1590	6	0.4	13	0.8	330	20.8	425	26.7	550	34.6	21	1.3	245	15.4
40-49	997	5	0.5	11	1.1	197	19.8	235	23.6	386	38.7	23	2.3	140	14.0
50-59	790	4	0.5	2	0.3	74	9.4	188	23.8	372	47.1	43	5.4	107	13.5
60-69	755	1	0.1	0	0.0	52	6.9	171	22.6	367	48.6	41	5.4	123	16.3
Total	4132	16	0.4	26	0.6	653	15.8	1019	24.7	1675	40.5	128	3.1	615	14.9

2023

Age group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	1034	13	1.3	14	1.4	409	39.6	274	26.5	230	22.2	12	1.2	82	7.9
40-49	679	10	1.5	18	2.7	251	37.0	185	27.2	164	24.2	5	0.7	46	6.8
50-59	423	6	1.4	3	0.7	105	24.8	115	27.2	126	29.8	17	4.0	51	12.1
60-69	332	2	0.6	1	0.3	82	24.7	83	25.0	114	34.3	15	4.5	35	10.5
Total	2468	31	1.3	36	1.5	847	34.3	657	26.6	634	25.7	49	2.0	214	8.7

Risk group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	1411	6	0.4	11	0.8	367	26.0	339	24.0	473	33.5	35	2.5	180	12.8
40-49	768	4	0.5	6	0.8	196	25.5	192	25.0	244	31.8	20	2.6	106	13.8
50-59	743	5	0.7	2	0.3	67	9.0	203	27.3	337	45.4	42	5.7	87	11.7
60-69	575	0	0.0	2	0.3	46	8.0	115	20.0	287	49.9	41	7.1	84	14.6
Total	3497	15	0.4	21	0.6	676	19.3	849	24.3	1341	38.3	138	3.9	457	13.1

2022

Age group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	837	4	0.5	18	2.2	395	47.2	214	25.6	175	20.9	10	1.2	21	2.5
40-49	645	15	2.3	18	2.8	263	40.8	171	26.5	144	22.3	12	1.9	22	3.4
50-59	379	0	0.0	3	0.8	101	26.6	117	30.9	126	33.2	16	4.2	16	4.2
60-69	256	1	0.4	1	0.4	57	22.3	78	30.5	94	36.7	17	6.6	8	3.1
Total	2117	20	0.9	40	1.9	816	38.5	580	27.4	539	25.5	55	2.6	67	3.2

Risk group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	1521	4	0.3	21	1.4	411	27.0	433	28.5	542	35.6	51	3.4	59	3.9
40-49	820	4	0.5	11	1.3	208	25.4	213	26.0	330	40.2	30	3.7	24	2.9
50-59	684	2	0.3	5	0.7	85	12.4	208	30.4	310	45.3	43	6.3	31	4.5
60-69	486	1	0.2	2	0.4	51	10.5	121	24.9	256	52.7	35	7.2	20	4.1
Total	3511	11	0.3	39	1.1	755	21.5	975	27.8	1438	41.0	159	4.5	134	3.8

2021

Age group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	932	18	1.9	13	1.4	430	46.1	214	23.0	160	17.2	22	2.4	75	8.0
40-49	574	10	1.7	9	1.6	248	43.2	134	23.3	115	20.0	10	1.7	48	8.4
50-59	378	8	2.1	4	1.1	111	29.4	105	27.8	105	27.8	10	2.6	35	9.3
60-69	160	2	1.2	3	1.9	44	27.5	41	25.6	45	28.1	4	2.5	21	13.1
Total	2044	38	1.9	29	1.4	833	40.8	494	24.2	425	20.8	46	2.3	179	8.8

Risk group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	1271	5	0.4	18	1.4	342	26.9	359	28.2	467	36.7	47	3.7	33	2.6
40-49	718	5	0.7	10	1.4	181	25.2	191	26.6	263	36.6	33	4.6	35	4.9
50-59	582	2	0.3	2	0.3	78	13.4	180	30.9	261	44.8	44	7.6	15	2.6
60-69	445	1	0.2	0	0.0	36	8.1	123	27.6	238	53.5	19	4.3	28	6.3
Total	3016	13	0.4	30	1.0	637	21.1	853	28.3	1229	40.7	143	4.7	111	3.7

2020

Age group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	687	7	1.0	15	2.2	352	51.2	144	21.0	114	16.6	43	6.3	12	1.7
40-49	467	10	2.1	14	3.0	214	45.8	99	21.2	87	18.6	40	8.6	3	0.6
50-59	315	7	2.2	5	1.6	102	32.4	73	23.2	100	31.7	28	8.9	0	0.0
60-69	160	3	1.9	2	1.2	49	30.6	37	23.1	50	31.2	18	11.2	1	0.6
Total	1629	27	1.7	36	2.2	717	44.0	353	21.7	351	21.5	129	7.9	16	1.0

Risk group screening

Age group	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
30-39	121	0	0.0	1	0.8	50	41.3	32	26.4	27	22.3	11	9.1	0	0.0
40-49	89	0	0.0	1	1.1	31	34.8	23	25.8	23	25.8	11	12.4	0	0.0
50-59	113	1	0.9	0	0.0	13	11.5	22	19.5	46	40.7	30	26.5	1	0.9
60-69	58	1	1.7	1	1.7	9	15.5	13	22.4	21	36.2	13	22.4	0	0.0
Total	381	2	0.5	3	0.8	103	27.0	90	23.6	117	30.7	65	17.1	1	0.3

Changes in cancer/precancer rate

Histological HSIL+

Proportion of referred

Population groups

Native language

Screening process

Age and risk group screening

2024

Native language	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Domestic	257719	196304	76.2	10488	5.3	6020	3.1	5103	84.8	1332	26.1
Other/missing	34391	19374	56.3	1088	5.6	557	2.9	485	87.1	159	32.8
Total	292110	215678	73.8	11576	5.4	6577	3.0	5588	85.0	1491	26.7

2023

Native language	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Domestic	256144	192995	75.3	10153	5.3	5482	2.8	4870	88.8	1480	30.4
Other/missing	30786	17731	57.6	1003	5.7	483	2.7	424	87.8	146	34.4
Total	286930	210726	73.4	11156	5.3	5965	2.8	5294	88.8	1626	30.7

2022

Native language	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Domestic	261145	194117	74.3	10221	5.3	5169	2.7	4980	96.3	1529	30.7
Other/missing	28408	16089	56.6	891	5.5	459	2.9	447	97.4	152	34.0
Total	289553	210206	72.6	11112	5.3	5628	2.7	5427	96.4	1681	31.0

2021

Native language	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Domestic	242289	181381	74.9	10343	5.7	4643	2.6	4375	94.2	1423	32.5
Other/missing	26088	15346	58.8	863	5.6	417	2.7	395	94.7	157	39.7
Total	268377	196727	73.3	11206	5.7	5060	2.6	4770	94.3	1580	33.1

2020

Native language	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Domestic	236544	170791	72.2	9246	5.4	1843	1.1	1829	99.2	811	44.3
Other/missing	25006	14144	56.6	814	5.8	167	1.2	164	98.2	77	47.0
Total	261550	184935	70.7	10060	5.4	2010	1.1	1993	99.2	888	44.6

Level of education

Screening process

Age and risk group screening

2024

Education	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Primary education/unknown	31338	15927	50.8	1007	6.3	499	3.1	423	84.8	153	36.2
Intermediate/secondary	112462	80606	71.7	4830	6.0	2780	3.4	2368	85.2	650	27.4
Tertiary/higher education	148310	119145	80.3	5739	4.8	3298	2.8	2797	84.8	688	24.6
Total	292110	215678	73.8	11576	5.4	6577	3.0	5588	85.0	1491	26.7

2023

Education	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Primary education/unknown	30510	15806	51.8	888	5.6	478	3.0	426	89.1	133	31.2
Intermediate/secondary	111926	79823	71.3	4740	5.9	2491	3.1	2227	89.4	731	32.8
Tertiary/higher education	144494	115097	79.7	5528	4.8	2996	2.6	2641	88.2	762	28.9
Total	286930	210726	73.4	11156	5.3	5965	2.8	5294	88.8	1626	30.7

2022

Education	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Primary education/unknown	30271	15735	52.0	907	5.8	431	2.7	416	96.5	151	36.3
Intermediate/secondary	114247	80809	70.7	4590	5.7	2348	2.9	2270	96.7	757	33.3
Tertiary/higher education	145035	113662	78.4	5615	4.9	2849	2.5	2741	96.2	773	28.2
Total	289553	210206	72.6	11112	5.3	5628	2.7	5427	96.4	1681	31.0

2021

Education	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Primary education/unknown	27817	14717	52.9	854	5.8	434	2.9	407	93.8	154	37.8
Intermediate/secondary	104763	75061	71.6	4641	6.2	2086	2.8	1955	93.7	709	36.3
Tertiary/higher education	135797	106949	78.8	5711	5.3	2540	2.4	2408	94.8	717	29.8
Total	268377	196727	73.3	11206	5.7	5060	2.6	4770	94.3	1580	33.1

2020

Education	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Primary education/unknown	27987	14407	51.5	799	5.5	173	1.2	170	98.3	84	49.4
Intermediate/secondary	103546	71949	69.5	4222	5.9	933	1.3	929	99.6	445	47.9
Tertiary/higher education	130017	98579	75.8	5039	5.1	904	0.9	894	98.9	359	40.2
Total	261550	184935	70.7	10060	5.4	2010	1.1	1993	99.2	888	44.6

Region of birth

Screening process

Age and risk group screening

2024

Region of birth	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Africa	2919	1429	49.0	95	6.6	35	2.4	29	82.9	8	27.6
Oceania	99	52	52.5	6	11.5	1	1.9	1	100.0	0	0.0
Americas	1413	818	57.9	36	4.4	30	3.7	24	80.0	5	20.8
Asia	12134	6495	53.5	385	5.9	173	2.7	151	87.3	61	40.4
Europe excl. Finland	19217	12075	62.8	637	5.3	354	2.9	309	87.3	87	28.2
Finland	256229	194743	76.0	10415	5.3	5981	3.1	5071	84.8	1328	26.2
Unknown	99	66	66.7	2	3.0	3	4.5	3	100.0	2	66.7
Total	292110	215678	73.8	11576	5.4	6577	3.0	5588	85.0	1491	26.7

2023

Region of birth	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Africa	2753	1328	48.2	72	5.4	22	1.7	20	90.9	4	20.0
Oceania	89	45	50.6	4	8.9	1	2.2	0	0.0	0	–
Americas	1362	786	57.7	58	7.4	28	3.6	22	78.6	6	27.3
Asia	10713	5851	54.6	311	5.3	158	2.7	138	87.3	52	37.7
Europe excl. Finland	18618	11812	63.4	645	5.5	343	2.9	301	87.8	106	35.2
Finland	253304	190839	75.3	10062	5.3	5412	2.8	4812	88.9	1458	30.3
Unknown	91	65	71.4	4	6.2	1	1.5	1	100.0	0	0.0
Total	286930	210726	73.4	11156	5.3	5965	2.8	5294	88.8	1626	30.7

2022

Region of birth	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Africa	2518	1154	45.8	59	5.1	28	2.4	28	100.0	4	14.3
Oceania	102	57	55.9	1	1.8	0	0.0	0	–	0	–
Americas	1279	713	55.7	47	6.6	15	2.1	13	86.7	4	30.8
Asia	9445	5128	54.3	266	5.2	141	2.7	137	97.2	51	37.2
Europe excl. Finland	18281	11431	62.5	623	5.5	344	3.0	332	96.5	110	33.1
Finland	257849	191672	74.3	10115	5.3	5099	2.7	4916	96.4	1512	30.8
Unknown	79	51	64.6	1	2.0	1	2.0	1	100.0	0	0.0
Total	289553	210206	72.6	11112	5.3	5628	2.7	5427	96.4	1681	31.0

2021

Region of birth	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Africa	2149	1036	48.2	52	5.0	25	2.4	25	100.0	10	40.0
Oceania	102	57	55.9	2	3.5	2	3.5	2	100.0	1	50.0
Americas	1181	659	55.8	39	5.9	19	2.9	18	94.7	6	33.3
Asia	8538	4959	58.1	260	5.2	136	2.7	128	94.1	57	44.5
Europe excl. Finland	17463	11148	63.8	637	5.7	297	2.7	280	94.3	111	39.6
Finland	238869	178822	74.9	10213	5.7	4580	2.6	4316	94.2	1395	32.3
Unknown	75	46	61.3	3	6.5	1	2.2	1	100.0	0	0.0
Total	268377	196727	73.3	11206	5.7	5060	2.6	4770	94.3	1580	33.1

2020

Region of birth	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Africa	2321	1119	48.2	69	6.2	12	1.1	12	100.0	5	41.7
Oceania	80	33	41.2	2	6.1	0	0.0	0	–	0	–
Americas	1035	557	53.8	41	7.4	6	1.1	6	100.0	2	33.3
Asia	7965	4403	55.3	251	5.7	57	1.3	54	94.7	27	50.0
Europe excl. Finland	16723	10291	61.5	586	5.7	128	1.2	128	100.0	62	48.4
Finland	233355	168487	72.2	9110	5.4	1806	1.1	1792	99.2	791	44.1
Unknown	71	45	63.4	1	2.2	1	2.2	1	100.0	1	100.0
Total	261550	184935	70.7	10060	5.4	2010	1.1	1993	99.2	888	44.6

Collaboration areas

Screening process

2024

Age group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	38724	27639	71.4	1519	5.5	377	1.4	345	91.5	132	38.3
Inland Finland	44267	32327	73.0	1936	6.0	438	1.4	411	93.8	153	37.2
Northern Finland	34429	25859	75.1	1318	5.1	312	1.2	245	78.5	106	43.3
Southern Finland	119440	87443	73.2	4851	5.5	943	1.1	891	94.5	336	37.7
Western Finland	42407	31834	75.1	1752	5.5	369	1.2	179	48.5	69	38.5
Total	279267	205102	73.4	11376	5.5	2439	1.2	2071	84.9	796	38.4

Risk group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	1632	1316	80.6	90	6.8	544	41.3	489	89.9	82	16.8
Inland Finland	1768	1485	84.0	0	0.0	734	49.4	651	88.7	127	19.5
Northern Finland	742	607	81.8	25	4.1	85	14.0	72	84.7	19	26.4
Southern Finland	5527	4555	82.4	8	0.2	2217	48.7	2085	94.0	421	20.2
Western Finland	1586	1339	84.4	0	0.0	545	40.7	220	40.4	46	20.9
Total	11255	9302	82.6	123	1.3	4125	44.3	3517	85.3	695	19.8

2023

Age group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	38539	26910	69.8	1470	5.5	362	1.3	348	96.1	141	40.5
Inland Finland	43656	31317	71.7	1682	5.4	418	1.3	407	97.4	168	41.3
Northern Finland	33994	24885	73.2	1048	4.2	255	1.0	220	86.3	82	37.3
Southern Finland	117191	86323	73.7	5125	5.9	990	1.1	945	95.5	350	37.0
Western Finland	42406	32156	75.8	1687	5.2	416	1.3	308	74.0	164	53.2
Total	275786	201591	73.1	11012	5.5	2441	1.2	2228	91.3	905	40.6

Risk group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	1146	879	76.7	24	2.7	346	39.4	335	96.8	61	18.2
Inland Finland	1689	1405	83.2	2	0.1	709	50.5	678	95.6	148	21.8
Northern Finland	623	510	81.9	54	10.6	62	12.2	56	90.3	11	19.6
Southern Finland	4277	3501	81.9	5	0.1	1653	47.2	1591	96.2	333	20.9
Western Finland	1791	1573	87.8	15	1.0	725	46.1	378	52.1	158	41.8
Total	9526	7868	82.6	100	1.3	3495	44.4	3038	86.9	711	23.4

2022

Age group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	39062	27378	70.1	1664	6.1	279	1.0	275	98.6	106	38.5
Inland Finland	43493	31584	72.6	1755	5.6	282	0.9	276	97.9	134	48.6
Northern Finland	34657	25475	73.5	872	3.4	259	1.0	237	91.5	96	40.5
Southern Finland	117556	84605	72.0	5003	5.9	870	1.0	844	97.0	368	43.6
Western Finland	42394	31447	74.2	1604	5.1	401	1.3	393	98.0	167	42.5
Total	277162	200489	72.3	10898	5.4	2091	1.0	2025	96.8	871	43.0

Risk group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	1323	968	73.2	47	4.9	329	34.0	319	97.0	53	16.6
Inland Finland	1977	1590	80.4	27	1.7	761	47.9	725	95.3	176	24.3
Northern Finland	469	387	82.5	32	8.3	41	10.6	40	97.6	17	42.5
Southern Finland	5336	4106	76.9	15	0.4	1853	45.1	1782	96.2	439	24.6
Western Finland	1641	1388	84.6	45	3.2	526	37.9	510	97.0	120	23.5
Total	10746	8439	78.5	166	2.0	3510	41.6	3376	96.2	805	23.8

2021

Age group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	33981	23898	70.3	1361	5.7	257	1.1	230	89.5	100	43.5
Inland Finland	37652	27932	74.2	1700	6.1	326	1.2	321	98.5	146	45.5
Northern Finland	30492	22546	73.9	797	3.5	197	0.9	125	63.5	71	56.8
Southern Finland	113905	82407	72.3	5027	6.1	966	1.2	934	96.7	439	47.0
Western Finland	39680	29585	74.6	1786	6.0	285	1.0	248	87.0	139	56.0
Total	255710	186368	72.9	10671	5.7	2031	1.1	1858	91.5	895	48.2

Risk group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	1184	960	81.1	140	14.6	278	29.0	269	96.8	65	24.2
Inland Finland	1518	1462	96.3	42	2.9	646	44.2	644	99.7	128	19.9
Northern Finland	590	484	82.0	53	11.0	21	4.3	15	71.4	7	46.7
Southern Finland	6570	5170	78.7	17	0.3	1846	35.7	1774	96.1	427	24.1
Western Finland	1394	1193	85.6	227	19.0	225	18.9	203	90.2	53	26.1
Total	11256	9269	82.3	479	5.2	3016	32.5	2905	96.3	680	23.4

2020

Age group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	34161	23532	68.9	1186	5.0	228	1.0	228	100.0	98	43.0
Inland Finland	37707	26582	70.5	1710	6.4	255	1.0	255	100.0	124	48.6
Northern Finland	30861	22419	72.6	441	2.0	183	0.8	183	100.0	85	46.4
Southern Finland	113683	79740	70.1	5015	6.3	662	0.8	646	97.6	330	51.1
Western Finland	39950	29005	72.6	1380	4.8	288	1.0	288	100.0	139	48.3
Total	256362	181278	70.7	9732	5.4	1616	0.9	1600	99.0	776	48.5

Risk group screening

Collaborative area	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Eastern Finland	1046	351	33.6	21	6.0	50	14.2	50	100.0	7	14.0
Inland Finland	412	357	86.7	43	12.0	61	17.1	61	100.0	14	23.0
Northern Finland	422	347	82.2	23	6.6	23	6.6	22	95.7	16	72.7
Southern Finland	493	315	63.9	29	9.2	52	16.5	52	100.0	16	30.8
Western Finland	1403	1171	83.5	179	15.3	195	16.7	195	100.0	55	28.2
Total	3776	2541	67.3	295	11.6	381	15.0	380	99.7	108	28.4

Screening results

Proportion of attended

2024

Age group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	27639	377	1.4	1519	5.5	25719	93.1	24	0.1	27431	99.2	1849	6.7
Inland Finland	32327	438	1.4	1936	6.0	29950	92.6	3	0.0	32325	100.0	2372	7.3
Northern Finland	25859	312	1.2	1318	5.1	24224	93.7	5	0.0	11940	46.2	939	7.9
Southern Finland	87443	943	1.1	4851	5.5	81647	93.4	2	0.0	87341	99.9	5782	6.6
Western Finland	31834	369	1.2	1752	5.5	29709	93.3	4	0.0	30025	94.3	1996	6.6
Total	205102	2439	1.2	11376	5.5	191249	93.2	38	0.0	189062	92.2	12938	6.8

Risk group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	1316	544	41.3	90	6.8	679	51.6	3	0.2	1305	99.2	630	48.3
Inland Finland	1485	734	49.4	0	0.0	751	50.6	0	0.0	1482	99.8	731	49.3
Northern Finland	607	85	14.0	25	4.1	497	81.9	0	0.0	300	49.4	54	18.0
Southern Finland	4555	2217	48.7	8	0.2	2329	51.1	1	0.0	4552	99.9	2225	48.9
Western Finland	1339	545	40.7	0	0.0	794	59.3	0	0.0	1339	100.0	545	40.7
Total	9302	4125	44.3	123	1.3	5050	54.3	4	0.0	8978	96.5	4185	46.6

2023

Age group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	26910	362	1.3	1470	5.5	25064	93.1	14	0.1	26561	98.7	1791	6.7
Inland Finland	31317	418	1.3	1682	5.4	29216	93.3	1	0.0	30687	98.0	2072	6.8
Northern Finland	24885	255	1.0	1048	4.2	23554	94.7	28	0.1	1	0.0	0	0.0
Southern Finland	86323	990	1.1	5125	5.9	80202	92.9	6	0.0	86202	99.9	6103	7.1
Western Finland	32156	416	1.3	1687	5.2	30020	93.4	33	0.1	22946	71.4	1565	6.8
Total	201591	2441	1.2	11012	5.5	188056	93.3	82	0.0	166397	82.5	11531	6.9

Risk group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	879	346	39.4	24	2.7	501	57.0	8	0.9	874	99.4	369	42.2
Inland Finland	1405	709	50.5	2	0.1	694	49.4	0	0.0	1390	98.9	709	51.0
Northern Finland	510	62	12.2	54	10.6	393	77.1	1	0.2	0	0.0	0	–
Southern Finland	3501	1653	47.2	5	0.1	1843	52.6	0	0.0	3499	99.9	1658	47.4
Western Finland	1573	725	46.1	15	1.0	832	52.9	1	0.1	1324	84.2	686	51.8
Total	7868	3495	44.4	100	1.3	4263	54.2	10	0.1	7087	90.1	3422	48.3

2022

Age group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	27378	279	1.0	1664	6.1	25413	92.8	22	0.1	25157	91.9	1689	6.7
Inland Finland	31584	282	0.9	1755	5.6	29527	93.5	20	0.1	26957	85.4	1833	6.8
Northern Finland	25475	259	1.0	872	3.4	24276	95.3	68	0.3	1	0.0	0	0.0
Southern Finland	84605	870	1.0	5003	5.9	78730	93.1	2	0.0	84396	99.8	5861	6.9
Western Finland	31447	401	1.3	1604	5.1	29405	93.5	37	0.1	19939	63.4	1358	6.8
Total	200489	2091	1.0	10898	5.4	187351	93.4	149	0.1	156450	78.0	10741	6.9

Risk group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	968	329	34.0	47	4.9	588	60.7	4	0.4	879	90.8	335	38.1
Inland Finland	1590	761	47.9	27	1.7	801	50.4	1	0.1	1459	91.8	740	50.7
Northern Finland	387	41	10.6	32	8.3	313	80.9	1	0.3	0	0.0	0	–
Southern Finland	4106	1853	45.1	15	0.4	2238	54.5	0	0.0	4102	99.9	1861	45.4
Western Finland	1388	526	37.9	45	3.2	817	58.9	0	0.0	1068	76.9	494	46.3
Total	8439	3510	41.6	166	2.0	4757	56.4	6	0.1	7508	89.0	3430	45.7

2021

Age group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	23898	257	1.1	1361	5.7	22268	93.2	12	0.1	11993	50.2	914	7.6
Inland Finland	27932	326	1.2	1700	6.1	25895	92.7	11	0.0	23968	85.8	1831	7.6
Northern Finland	22546	197	0.9	797	3.5	21483	95.3	69	0.3	5	0.0	0	0.0
Southern Finland	82407	966	1.2	5027	6.1	76411	92.7	3	0.0	77948	94.6	5846	7.5
Western Finland	29585	285	1.0	1786	6.0	27471	92.9	43	0.1	18930	64.0	1485	7.8
Total	186368	2031	1.1	10671	5.7	173528	93.1	138	0.1	132844	71.3	10076	7.6

Risk group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	960	278	29.0	140	14.6	538	56.0	4	0.4	654	68.1	335	51.2
Inland Finland	1462	646	44.2	42	2.9	774	52.9	0	0.0	1313	89.8	638	48.6
Northern Finland	484	21	4.3	53	11.0	409	84.5	1	0.2	3	0.6	0	0.0
Southern Finland	5170	1846	35.7	17	0.3	3307	64.0	0	0.0	5027	97.2	1838	36.6
Western Finland	1193	225	18.9	227	19.0	740	62.0	1	0.1	817	68.5	367	44.9
Total	9269	3016	32.5	479	5.2	5768	62.2	6	0.1	7814	84.3	3178	40.7

2020

Age group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	23532	228	1.0	1186	5.0	22116	94.0	2	0	11666	49.6	858	7.4
Inland Finland	26582	255	1.0	1710	6.4	24617	92.6	0	0	22233	83.6	1753	7.9
Northern Finland	22419	183	0.8	441	2.0	21795	97.2	0	0	15	0.1	4	26.7
Southern Finland	79740	662	0.8	5015	6.3	74051	92.9	12	0	69128	86.7	5324	7.7
Western Finland	29005	288	1.0	1380	4.8	27334	94.2	3	0	15050	51.9	1119	7.4
Total	181278	1616	0.9	9732	5.4	169913	93.7	17	0	118092	65.1	9058	7.7

Risk group screening

Collaborative area	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	351	50	14.2	21	6.0	280	79.8	0	0	218	62.1	45	20.6
Inland Finland	357	61	17.1	43	12.0	253	70.9	0	0	232	65.0	80	34.5
Northern Finland	347	23	6.6	23	6.6	301	86.7	0	0	0	0.0	0	–
Southern Finland	315	52	16.5	29	9.2	234	74.3	0	0	84	26.7	24	28.6
Western Finland	1171	195	16.7	179	15.3	797	68.1	0	0	746	63.7	294	39.4
Total	2541	381	15.0	295	11.6	1865	73.4	0	0	1280	50.4	443	34.6

Histological findings

Proportion of referred

2024

Age group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	377	5	1.3	5	1.3	122	32.4	150	39.8	50	13.3	13	3.4	32	8.5
Inland Finland	438	4	0.9	4	0.9	145	33.1	117	26.7	134	30.6	7	1.6	27	6.2
Northern Finland	312	4	1.3	5	1.6	97	31.1	57	18.3	76	24.4	6	1.9	67	21.5
Southern Finland	943	12	1.3	14	1.5	310	32.9	234	24.8	314	33.3	7	0.7	52	5.5
Western Finland	369	2	0.5	5	1.4	62	16.8	54	14.6	48	13.0	8	2.2	190	51.5
Total	2439	27	1.1	33	1.4	736	30.2	612	25.1	622	25.5	41	1.7	368	15.1

Risk group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	544	1	0.2	1	0.2	80	14.7	268	49.3	103	18.9	36	6.6	55	10.1
Inland Finland	734	1	0.1	5	0.7	121	16.5	137	18.7	364	49.6	23	3.1	83	11.3
Northern Finland	85	0	0.0	0	0.0	19	22.4	15	17.6	36	42.4	2	2.4	13	15.3
Southern Finland	2217	14	0.6	18	0.8	389	17.5	561	25.3	1075	48.5	28	1.3	132	6.0
Western Finland	545	0	0.0	2	0.4	44	8.1	38	7.0	97	17.8	39	7.2	325	59.6
Total	4125	16	0.4	26	0.6	653	15.8	1019	24.7	1675	40.6	128	3.1	608	14.7

2023

Age group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	362	4	1.1	2	0.6	135	37.3	155	42.8	40	11.0	12	3.3	14	3.9
Inland Finland	418	4	1.0	8	1.9	156	37.3	118	28.2	111	26.6	10	2.4	11	2.6
Northern Finland	255	2	0.8	6	2.4	74	29.0	35	13.7	97	38.0	6	2.4	35	13.7
Southern Finland	990	15	1.5	11	1.1	324	32.7	296	29.9	291	29.4	8	0.8	45	4.5
Western Finland	416	5	1.2	9	2.2	150	36.1	50	12.0	81	19.5	13	3.1	108	26.0
Total	2441	30	1.2	36	1.5	839	34.4	654	26.8	620	25.4	49	2.0	213	8.7

Risk group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	346	1	0.3	2	0.6	58	16.8	197	56.9	56	16.2	21	6.1	11	3.2
Inland Finland	709	2	0.3	5	0.7	141	19.9	164	23.1	316	44.6	50	7.1	31	4.4
Northern Finland	62	0	0.0	0	0.0	11	17.7	9	14.5	36	58.1	0	0.0	6	9.7
Southern Finland	1653	9	0.5	11	0.7	313	18.9	432	26.1	802	48.5	24	1.5	62	3.8
Western Finland	725	3	0.4	3	0.4	152	21.0	47	6.5	130	17.9	43	5.9	347	47.9
Total	3495	15	0.4	21	0.6	675	19.3	849	24.3	1340	38.3	138	3.9	457	13.1

2022

Age group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	279	0	0.0	8	2.9	98	35.1	114	40.9	41	14.7	14	5.0	4	1.4
Inland Finland	282	1	0.4	7	2.5	126	44.7	66	23.4	68	24.1	8	2.8	6	2.1
Northern Finland	259	6	2.3	2	0.8	88	34.0	62	23.9	75	29.0	4	1.5	22	8.5
Southern Finland	870	9	1.0	15	1.7	344	39.5	240	27.6	231	26.6	5	0.6	26	3.0
Western Finland	401	3	0.7	8	2.0	156	38.9	91	22.7	112	27.9	23	5.7	8	2.0
Total	2091	19	0.9	40	1.9	812	38.8	573	27.4	527	25.2	54	2.6	66	3.2

Risk group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	329	1	0.3	2	0.6	50	15.2	188	57.1	54	16.4	24	7.3	10	3.0
Inland Finland	761	0	0.0	6	0.8	170	22.3	153	20.1	342	44.9	54	7.1	36	4.7
Northern Finland	41	0	0.0	0	0.0	17	41.5	7	17.1	14	34.1	2	4.9	1	2.4
Southern Finland	1853	8	0.4	26	1.4	405	21.9	525	28.3	793	42.8	25	1.3	71	3.8
Western Finland	526	2	0.4	5	1.0	113	21.5	101	19.2	235	44.7	54	10.3	16	3.0
Total	3510	11	0.3	39	1.1	755	21.5	974	27.7	1438	41.0	159	4.5	134	3.8

2021

Age group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	257	8	3.1	2	0.8	90	35.0	80	31.1	42	16.3	8	3.1	27	10.5
Inland Finland	326	8	2.5	7	2.1	131	40.2	77	23.6	76	23.3	22	6.7	5	1.5
Northern Finland	197	2	1.0	1	0.5	68	34.5	31	15.7	20	10.2	3	1.5	72	36.5
Southern Finland	966	17	1.8	12	1.2	410	42.4	252	26.1	238	24.6	5	0.5	32	3.3
Western Finland	285	3	1.1	6	2.1	130	45.6	54	18.9	47	16.5	8	2.8	37	13.0
Total	2031	38	1.9	28	1.4	829	40.8	494	24.3	423	20.8	46	2.3	173	8.5

Risk group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	278	0	0.0	3	1.1	62	22.3	151	54.3	37	13.3	16	5.8	9	3.2
Inland Finland	646	3	0.5	4	0.6	121	18.7	145	22.4	292	45.2	79	12.2	2	0.3
Northern Finland	21	1	4.8	1	4.8	5	23.8	2	9.5	5	23.8	1	4.8	6	28.6
Southern Finland	1846	8	0.4	19	1.0	400	21.7	511	27.7	813	44.0	23	1.2	72	3.9
Western Finland	225	1	0.4	3	1.3	49	21.8	44	19.6	82	36.4	24	10.7	22	9.8
Total	3016	13	0.4	30	1.0	637	21.1	853	28.3	1229	40.7	143	4.7	111	3.7

2020

Age group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	228	1	0.4	6	2.6	91	39.9	68	29.8	34	14.9	28	12.3	0	0.0
Inland Finland	255	3	1.2	6	2.4	115	45.1	44	17.3	53	20.8	34	13.3	0	0.0
Northern Finland	183	1	0.5	2	1.1	82	44.8	36	19.7	46	25.1	16	8.7	0	0.0
Southern Finland	662	17	2.6	15	2.3	298	45.0	149	22.5	157	23.7	10	1.5	16	2.4
Western Finland	288	5	1.7	7	2.4	127	44.1	52	18.1	57	19.8	40	13.9	0	0.0
Total	1616	27	1.7	36	2.2	713	44.1	349	21.6	347	21.5	128	7.9	16	1.0

Risk group screening

Collaborative area	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Eastern Finland	50	0	0.0	0	0.0	7	14.0	28	56.0	7	14.0	8	16.0	0	0.0
Inland Finland	61	0	0.0	0	0.0	14	23.0	16	26.2	22	36.1	9	14.8	0	0.0
Northern Finland	23	1	4.3	1	4.3	14	60.9	1	4.3	2	8.7	3	13.0	1	4.3
Southern Finland	52	0	0.0	0	0.0	16	30.8	11	21.2	18	34.6	7	13.5	0	0.0
Western Finland	195	1	0.5	2	1.0	52	26.7	34	17.4	68	34.9	38	19.5	0	0.0
Total	381	2	0.5	3	0.8	103	27.0	90	23.6	117	30.7	65	17.1	1	0.3

Wellbeing services counties

Screening process

2024

Age group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	13086	9182	70.2	482	5.2	111	1.2	91	82.0	32	35.2
Central Ostrobothnia	3114	2152	69.1	107	5.0	30	1.4	28	93.3	12	42.9
Central Uusimaa	10808	8294	76.7	416	5.0	89	1.1	87	97.8	34	39.1
City of Helsinki	38382	27514	71.7	1753	6.4	277	1.0	260	93.9	105	40.4
East Uusimaa	5125	3909	76.3	179	4.6	24	0.6	23	95.8	9	39.1
Kainuu	3305	2594	78.5	72	2.8	13	0.5	10	76.9	6	60.0
Kanta-Häme	8312	5814	69.9	361	6.2	88	1.5	80	90.9	30	37.5
Kymenlaakso	7751	5968	77.0	317	5.3	63	1.1	57	90.5	24	42.1
Lapland	8555	6825	79.8	485	7.1	123	1.8	100	81.3	34	34.0
North Karelia	7572	5135	67.8	205	4.0	93	1.8	91	97.8	37	40.7
North Ostrobothnia	19455	14288	73.4	654	4.6	146	1.0	107	73.3	54	50.5
North Savo	12037	8367	69.5	530	6.3	110	1.3	106	96.4	40	37.7
Ostrobothnia	8088	5841	72.2	267	4.6	80	1.4	78	97.5	33	42.3
Pirkanmaa	27033	19198	71.0	1172	6.1	255	1.3	242	94.9	85	35.1
Päijät-Häme	9996	6817	68.2	423	6.2	111	1.6	107	96.4	38	35.5
Satakunta	10022	7170	71.5	420	5.9	99	1.4	97	98.0	34	35.1
South Karelia	5942	4560	76.7	230	5.0	59	1.3	49	83.1	20	40.8
South Ostrobothnia	8922	7315	82.0	403	5.5	95	1.3	89	93.7	38	42.7
South Savo	6029	4955	82.2	302	6.1	63	1.3	57	90.5	23	40.4
Southwest Finland	24297	18823	77.5	1065	5.7	190	1.0	4	2.1	2	50.0
Vantaa and Kerava	15285	10952	71.7	616	5.6	139	1.3	134	96.4	51	38.1
West Uusimaa	26151	19429	74.3	917	4.7	181	0.9	174	96.1	55	31.6
Åland	1545	1235	79.9	77	6.2	6	0.5	0	0.0	0	–
Total	280812	206337	73.5	11453	5.6	2445	1.2	2071	84.7	796	38.4

Risk group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	538	443	82.3	0	0.0	198	44.7	165	83.3	24	14.5
Central Ostrobothnia	63	48	76.2	0	0.0	8	16.7	5	62.5	2	40.0
Central Uusimaa	443	364	82.2	2	0.5	175	48.1	170	97.1	62	36.5
City of Helsinki	1972	1613	81.8	3	0.2	797	49.4	748	93.9	146	19.5
East Uusimaa	223	183	82.1	0	0.0	93	50.8	91	97.8	32	35.2
Kainuu	47	38	80.9	4	10.5	2	5.3	2	100.0	1	50.0
Kanta-Häme	315	259	82.2	0	0.0	126	48.6	108	85.7	19	17.6
Kymenlaakso	407	340	83.5	0	0.0	152	44.7	144	94.7	27	18.8
Lapland	211	178	84.4	4	2.2	29	16.3	24	82.8	5	20.8
North Karelia	332	242	72.9	2	0.8	125	51.7	121	96.8	19	15.7
North Ostrobothnia	421	343	81.5	17	5.0	46	13.4	41	89.1	11	26.8
North Savo	485	394	81.2	4	1.0	205	52.0	187	91.2	34	18.2
Ostrobothnia	264	205	77.7	0	0.0	23	11.2	22	95.7	10	45.5
Pirkanmaa	1085	898	82.8	0	0.0	489	54.5	437	89.4	86	19.7
Päijät-Häme	398	341	85.7	0	0.0	183	53.7	169	92.3	28	16.6
Satakunta	401	345	86.0	0	0.0	202	58.6	197	97.5	36	18.3
South Karelia	270	223	82.6	0	0.0	101	45.3	85	84.2	11	12.9
South Ostrobothnia	368	328	89.1	0	0.0	119	36.3	106	89.1	22	20.8
South Savo	277	237	85.6	84	35.4	16	6.8	16	100.0	5	31.2
Southwest Finland	921	789	85.7	0	0.0	320	40.6	1	0.3	0	0.0
Vantaa and Kerava	710	576	81.1	1	0.2	302	52.4	282	93.4	45	16.0
West Uusimaa	1104	915	82.9	2	0.2	414	45.2	396	95.7	70	17.7
Åland	43	39	90.7	0	0.0	7	17.9	0	0.0	0	–
Total	11298	9341	82.7	123	1.3	4132	44.2	3517	85.1	695	19.8

2023

Age group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	12867	8702	67.6	413	4.7	131	1.5	125	95.4	38	30.4
Central Ostrobothnia	2995	2145	71.6	86	4.0	27	1.3	27	100.0	12	44.4
Central Uusimaa	10638	8045	75.6	490	6.1	84	1.0	80	95.2	38	47.5
City of Helsinki	37770	27385	72.5	1802	6.6	333	1.2	311	93.4	113	36.3
East Uusimaa	5047	3870	76.7	188	4.9	37	1.0	36	97.3	17	47.2
Kainuu	3222	2464	76.5	72	2.9	20	0.8	12	60.0	1	8.3
Kanta-Häme	8288	5677	68.5	292	5.1	82	1.4	79	96.3	28	35.4
Kymenlaakso	7718	5967	77.3	346	5.8	56	0.9	53	94.6	22	41.5
Lapland	8633	6208	71.9	340	5.5	80	1.3	63	78.8	26	41.3
North Karelia	7651	4926	64.4	240	4.9	80	1.6	77	96.2	39	50.6
North Ostrobothnia	19144	14068	73.5	550	3.9	128	0.9	118	92.2	43	36.4
North Savo	11969	8250	68.9	509	6.2	103	1.2	99	96.1	38	38.4
Ostrobothnia	8156	6222	76.3	265	4.3	41	0.7	37	90.2	15	40.5
Pirkanmaa	26461	18603	70.3	1017	5.5	254	1.4	248	97.6	100	40.3
Päijät-Häme	10080	7055	70.0	433	6.1	128	1.8	121	94.5	40	33.1
Satakunta	10081	7317	72.6	402	5.5	149	2.0	147	98.7	57	38.8
South Karelia	5922	4574	77.2	242	5.3	54	1.2	53	98.1	5	9.4
South Ostrobothnia	8907	7037	79.0	373	5.3	82	1.2	80	97.6	40	50.0
South Savo	6052	5032	83.1	308	6.1	48	1.0	47	97.9	26	55.3
Southwest Finland	24169	18617	77.0	1020	5.5	226	1.2	124	54.9	92	74.2
Vantaa and Kerava	14711	10665	72.5	671	6.3	124	1.2	123	99.2	49	39.8
West Uusimaa	25305	18762	74.1	953	5.1	174	0.9	168	96.6	66	39.3
Åland	1581	1235	78.1	41	3.3	27	2.2	26	96.3	9	34.6
Total	277367	202826	73.1	11053	5.4	2468	1.2	2254	91.3	914	40.6

Risk group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	522	411	78.7	0	0.0	189	46.0	183	96.8	27	14.8
Central Ostrobothnia	78	63	80.8	6	9.5	7	11.1	7	100.0	0	0.0
Central Uusimaa	399	318	79.7	0	0.0	153	48.1	147	96.1	43	29.3
City of Helsinki	1493	1230	82.4	4	0.3	584	47.5	557	95.4	104	18.7
East Uusimaa	172	130	75.6	0	0.0	55	42.3	54	98.2	17	31.5
Kainuu	64	48	75.0	4	8.3	6	12.5	6	100.0	1	16.7
Kanta-Häme	294	249	84.7	0	0.0	127	51.0	118	92.9	22	18.6
Kymenlaakso	362	304	84.0	0	0.0	131	43.1	128	97.7	14	10.9
Lapland	136	106	77.9	12	11.3	19	17.9	18	94.7	6	33.3
North Karelia	383	279	72.8	2	0.7	138	49.5	133	96.4	28	21.1
North Ostrobothnia	345	293	84.9	32	10.9	30	10.2	25	83.3	4	16.0
North Savo	69	41	59.4	4	9.8	8	19.5	8	100.0	1	12.5
Ostrobothnia	267	222	83.1	11	5.0	37	16.7	33	89.2	7	21.2
Pirkanmaa	1050	868	82.7	0	0.0	491	56.6	476	96.9	104	21.8
Päijät-Häme	372	301	80.9	0	0.0	167	55.5	163	97.6	40	24.5
Satakunta	445	386	86.7	0	0.0	237	61.4	235	99.2	51	21.7
South Karelia	69	57	82.6	0	0.0	14	24.6	12	85.7	3	25.0
South Ostrobothnia	345	288	83.5	2	0.7	91	31.6	84	92.3	22	26.2
South Savo	172	148	86.0	18	12.2	11	7.4	11	100.0	5	45.5
Southwest Finland	1079	965	89.4	4	0.4	451	46.7	110	24.4	100	90.9
Vantaa and Kerava	566	475	83.9	1	0.2	239	50.3	233	97.5	45	19.3
West Uusimaa	844	686	81.3	0	0.0	310	45.2	297	95.8	67	22.6
Åland	37	32	86.5	3	9.4	2	6.2	2	100.0	1	50.0
Total	9563	7900	82.6	103	1.3	3497	44.3	3040	86.9	712	23.4

2022

Age group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	12927	9232	71.4	568	6.2	77	0.8	76	98.7	27	35.5
Central Ostrobothnia	3187	2388	74.9	69	2.9	19	0.8	19	100.0	7	36.8
Central Uusimaa	10531	7849	74.5	368	4.7	73	0.9	71	97.3	33	46.5
City of Helsinki	37763	26753	70.8	1758	6.6	330	1.2	321	97.3	132	41.1
East Uusimaa	5197	3856	74.2	182	4.7	31	0.8	31	100.0	12	38.7
Kainuu	3327	2486	74.7	71	2.9	17	0.7	17	100.0	7	41.2
Kanta-Häme	8416	6057	72.0	316	5.2	47	0.8	45	95.7	20	44.4
Kymenlaakso	7995	6007	75.1	370	6.2	69	1.1	67	97.1	27	40.3
Lapland	8593	6229	72.5	225	3.6	62	1.0	60	96.8	22	36.7
North Karelia	7691	5127	66.7	310	6.0	69	1.3	67	97.1	29	43.3
North Ostrobothnia	19550	14372	73.5	507	3.5	161	1.1	141	87.6	60	42.6
North Savo	12239	8229	67.2	501	6.1	85	1.0	84	98.8	33	39.3
Ostrobothnia	8067	6164	76.4	270	4.4	63	1.0	63	100.0	29	46.0
Pirkanmaa	26280	18811	71.6	1094	5.8	182	1.0	178	97.8	93	52.2
Päijät-Häme	10045	7136	71.0	413	5.8	72	1.0	71	98.6	48	67.6
Satakunta	10255	7549	73.6	408	5.4	73	1.0	72	98.6	29	40.3
South Karelia	5990	4328	72.3	270	6.2	17	0.4	17	100.0	2	11.8
South Ostrobothnia	8797	6716	76.3	345	5.1	53	0.8	53	100.0	21	39.6
South Savo	6205	4790	77.2	285	5.9	48	1.0	48	100.0	17	35.4
Southwest Finland	24072	17734	73.7	926	5.2	265	1.5	258	97.4	109	42.2
Vantaa and Kerava	14552	10181	70.0	645	6.3	135	1.3	130	96.3	54	41.5
West Uusimaa	25483	18495	72.6	997	5.4	143	0.8	136	95.1	60	44.1
Åland	1611	1252	77.7	46	3.7	26	2.1	25	96.2	5	20.0
Total	278773	201741	72.4	10944	5.4	2117	1.0	2050	96.8	876	42.7

Risk group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	604	467	77.3	18	3.9	205	43.9	197	96.1	34	17.3
Central Ostrobothnia	77	62	80.5	2	3.2	4	6.5	4	100.0	1	25.0
Central Uusimaa	521	403	77.4	2	0.5	201	49.9	193	96.0	64	33.2
City of Helsinki	1966	1491	75.8	5	0.3	691	46.3	665	96.2	158	23.8
East Uusimaa	248	192	77.4	3	1.6	84	43.8	78	92.9	16	20.5
Kainuu	40	35	87.5	2	5.7	2	5.7	2	100.0	2	100.0
Kanta-Häme	314	260	82.8	6	2.3	127	48.8	120	94.5	27	22.5
Kymenlaakso	117	96	82.1	0	0.0	20	20.8	19	95.0	4	21.1
Lapland	109	87	79.8	9	10.3	10	11.5	10	100.0	8	80.0
North Karelia	289	182	63.0	0	0.0	104	57.1	103	99.0	15	14.6
North Ostrobothnia	243	203	83.5	19	9.4	25	12.3	24	96.0	6	25.0
North Savo	243	164	67.5	12	7.3	4	2.4	4	100.0	1	25.0
Ostrobothnia	233	195	83.7	19	9.7	14	7.2	14	100.0	1	7.1
Pirkanmaa	1261	1030	81.7	10	1.0	525	51.0	505	96.2	131	25.9
Päijät-Häme	479	381	79.5	2	0.5	187	49.1	184	98.4	54	29.3
Satakunta	560	482	86.1	4	0.8	235	48.8	232	98.7	46	19.8
South Karelia	138	106	76.8	0	0.0	20	18.9	18	90.0	4	22.2
South Ostrobothnia	402	300	74.6	11	3.7	109	36.3	100	91.7	18	18.0
South Savo	187	155	82.9	17	11.0	16	10.3	15	93.8	3	20.0
Southwest Finland	848	711	83.8	22	3.1	277	39.0	264	95.3	73	27.7
Vantaa and Kerava	766	577	75.3	1	0.2	274	47.5	264	96.4	62	23.5
West Uusimaa	1101	860	78.1	2	0.2	376	43.7	361	96.0	77	21.3
Åland	34	26	76.5	2	7.7	1	3.8	1	100.0	0	0.0
Total	10780	8465	78.5	168	2.0	3511	41.5	3377	96.2	805	23.8

2021

Age group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	11094	8068	72.7	570	7.1	102	1.3	102	100.0	45	44.1
Central Ostrobothnia	2721	2020	74.2	76	3.8	17	0.8	10	58.8	6	60.0
Central Uusimaa	10324	7627	73.9	420	5.5	71	0.9	70	98.6	42	60.0
City of Helsinki	37239	26570	71.3	1887	7.1	370	1.4	356	96.2	153	43.0
East Uusimaa	5000	3605	72.1	196	5.4	42	1.2	41	97.6	20	48.8
Kainuu	3374	2610	77.4	73	2.8	19	0.7	11	57.9	5	45.5
Kanta-Häme	7332	5223	71.2	286	5.5	55	1.1	52	94.5	27	51.9
Kymenlaakso	7953	6060	76.2	407	6.7	44	0.7	43	97.7	25	58.1
Lapland	7366	5398	73.3	168	3.1	48	0.9	40	83.3	23	57.5
North Karelia	6467	4697	72.6	314	6.7	48	1.0	33	68.8	17	51.5
North Ostrobothnia	17031	12518	73.5	480	3.8	113	0.9	64	56.6	37	57.8
North Savo	11242	7383	65.7	301	4.1	71	1.0	60	84.5	27	45.0
Ostrobothnia	7264	5595	77.0	262	4.7	43	0.8	36	83.7	13	36.1
Pirkanmaa	22747	16781	73.8	1083	6.5	229	1.4	229	100.0	96	41.9
Päijät-Häme	8441	6074	72.0	429	7.1	95	1.6	90	94.7	49	54.4
Satakunta	10306	7615	73.9	472	6.2	102	1.3	102	100.0	61	59.8
South Karelia	5083	3791	74.6	69	1.8	28	0.7	28	100.0	8	28.6
South Ostrobothnia	7573	5928	78.3	331	5.6	42	0.7	40	95.2	23	57.5
South Savo	5178	3750	72.4	176	4.7	36	1.0	35	97.2	11	31.4
Southwest Finland	22110	16375	74.1	1052	6.4	140	0.9	110	78.6	65	59.1
Vantaa and Kerava	14589	10515	72.1	674	6.4	144	1.4	140	97.2	68	48.6
West Uusimaa	25276	18165	71.9	945	5.2	172	0.9	166	96.5	74	44.6
Åland	1383	1069	77.3	51	4.8	13	1.2	7	53.8	5	71.4
Total	257093	187437	72.9	10722	5.7	2044	1.1	1865	91.2	900	48.3

Risk group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	539	510	94.6	12	2.4	244	47.8	244	100.0	53	21.7
Central Ostrobothnia	95	81	85.3	7	8.6	1	1.2	1	100.0	0	0.0
Central Uusimaa	692	545	78.8	1	0.2	194	35.6	185	95.4	45	24.3
City of Helsinki	2455	1952	79.5	5	0.3	707	36.2	674	95.3	154	22.8
East Uusimaa	285	230	80.7	1	0.4	90	39.1	87	96.7	25	28.7
Kainuu	60	47	78.3	6	12.8	2	4.3	1	50.0	1	100.0
Kanta-Häme	251	250	99.6	2	0.8	126	50.4	126	100.0	26	20.6
Kymenlaakso	164	93	56.7	2	2.2	18	19.4	17	94.4	5	29.4
Lapland	135	116	85.9	14	12.1	9	7.8	9	100.0	4	44.4
North Karelia	301	207	68.8	83	40.1	21	10.1	14	66.7	5	35.7
North Ostrobothnia	300	240	80.0	26	10.8	9	3.8	4	44.4	2	50.0
North Savo	199	110	55.3	23	20.9	9	8.2	7	77.8	4	57.1
Ostrobothnia	239	198	82.8	27	13.6	13	6.6	11	84.6	4	36.4
Pirkanmaa	1015	1015	100.0	2	0.2	513	50.5	513	100.0	100	19.5
Päijät-Häme	311	308	99.0	3	1.0	176	57.1	175	99.4	42	24.0
Satakunta	291	291	100.0	0	0.0	159	54.6	159	100.0	24	15.1
South Karelia	271	124	45.8	0	0.0	14	11.3	12	85.7	3	25.0
South Ostrobothnia	252	197	78.2	38	19.3	7	3.6	5	71.4	2	40.0
South Savo	145	133	91.7	22	16.5	4	3.0	4	100.0	3	75.0
Southwest Finland	864	704	81.5	200	28.4	53	7.5	33	62.3	25	75.8
Vantaa and Kerava	1020	808	79.2	2	0.2	269	33.3	258	95.9	64	24.8
West Uusimaa	1372	1110	80.9	3	0.3	378	34.1	366	96.8	89	24.3
Åland	28	21	75.0	5	23.8	0	0.0	0	–	0	–
Total	11284	9290	82.3	484	5.2	3016	32.5	2905	96.3	680	23.4

2020

Age group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	11090	7503	67.7	519	6.9	66	0.9	66	100.0	25	37.9
Central Ostrobothnia	2742	2017	73.6	70	3.5	18	0.9	18	100.0	5	27.8
Central Uusimaa	10269	7658	74.6	462	6.0	61	0.8	61	100.0	42	68.9
City of Helsinki	37752	25531	67.6	1937	7.6	239	0.9	228	95.4	105	46.1
East Uusimaa	4978	3643	73.2	229	6.3	27	0.7	27	100.0	16	59.3
Kainuu	3510	2643	75.3	41	1.6	13	0.5	13	100.0	3	23.1
Kanta-Häme	7266	4815	66.3	274	5.7	43	0.9	43	100.0	10	23.3
Kymenlaakso	8164	6095	74.7	117	1.9	49	0.8	49	100.0	25	51.0
Lapland	7379	5370	72.8	100	1.9	35	0.7	35	100.0	20	57.1
North Karelia	6610	4946	74.8	291	5.9	53	1.1	53	100.0	26	49.1
North Ostrobothnia	17230	12389	71.9	230	1.9	117	0.9	117	100.0	57	48.7
North Savo	10979	6917	63.0	145	2.1	76	1.1	76	100.0	28	36.8
Ostrobothnia	7329	5533	75.5	201	3.6	43	0.8	43	100.0	18	41.9
Pirkanmaa	22546	15621	69.3	1069	6.8	164	1.0	164	100.0	86	52.4
Päijät-Häme	8580	5782	67.4	393	6.8	46	0.8	46	100.0	19	41.3
Satakunta	10416	7459	71.6	478	6.4	84	1.1	84	100.0	39	46.4
South Karelia	5189	3714	71.6	116	3.1	34	0.9	34	100.0	15	44.1
South Ostrobothnia	7895	6146	77.8	367	6.0	48	0.8	48	100.0	28	58.3
South Savo	5482	4166	76.0	231	5.5	33	0.8	33	100.0	19	57.6
Southwest Finland	22205	16013	72.1	701	4.4	161	1.0	161	100.0	82	50.9
Vantaa and Kerava	14144	10113	71.5	715	7.1	96	0.9	93	96.9	48	51.6
West Uusimaa	24607	17204	69.9	1046	6.1	110	0.6	108	98.2	60	55.6
Åland	1394	1105	79.3	30	2.7	13	1.2	13	100.0	4	30.8
Total	257756	182383	70.8	9762	5.4	1629	0.9	1613	99.0	780	48.4

Risk group screening

Wellbeing service county	Invited	Attended (of invited)		Follow-up recommendation (of those who participated)		Referral to colposcopy (of those who participated)		Attended colposcopy (of those referred)		Histological HSIL or worse (of those who had colposcopy)
	N	N	%	N	%	N	%	N	%	N	%
Central Finland	265	197	74.3	10	5.1	46	23.4	46	100.0	7	15.2
Central Ostrobothnia	44	38	86.4	7	18.4	1	2.6	1	100.0	1	100.0
City of Helsinki	1	1	100.0	0	0.0	0	0.0	0	–	0	–
East Uusimaa	1	1	100.0	0	0.0	0	0.0	0	–	0	–
Kainuu	34	26	76.5	0	0.0	0	0.0	0	–	0	–
Kanta-Häme	29	26	89.7	1	3.8	6	23.1	6	100.0	0	0.0
Kymenlaakso	157	117	74.5	0	0.0	17	14.5	17	100.0	4	23.5
Lapland	148	119	80.4	9	7.6	15	12.6	14	93.3	11	78.6
North Karelia	114	85	74.6	4	4.7	2	2.4	2	100.0	0	0.0
North Ostrobothnia	196	164	83.7	7	4.3	7	4.3	7	100.0	4	57.1
North Savo	367	13	3.5	3	23.1	2	15.4	2	100.0	0	0.0
Ostrobothnia	224	191	85.3	28	14.7	6	3.1	6	100.0	2	33.3
Pirkanmaa	89	89	100.0	0	0.0	47	52.8	47	100.0	8	17.0
Päijät-Häme	132	89	67.4	2	2.2	28	31.5	28	100.0	8	28.6
Satakunta	410	335	81.7	0	0.0	152	45.4	152	100.0	33	21.7
South Karelia	202	107	53.0	27	25.2	7	6.5	7	100.0	4	57.1
South Ostrobothnia	294	242	82.3	42	17.4	8	3.3	8	100.0	6	75.0
South Savo	300	56	18.7	4	7.1	0	0.0	0	–	0	–
Southwest Finland	769	645	83.9	151	23.4	37	5.7	37	100.0	20	54.1
Åland	18	11	61.1	3	27.3	0	0.0	0	–	0	–
Total	3794	2552	67.3	298	11.7	381	14.9	380	99.7	108	28.4

Screening results

Proportion of attended

2024

Age group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	9182	111	1.2	482	5.2	8589	93.5	0	0.0	9140	99.5	590	6.5
Central Ostrobothnia	2152	30	1.4	107	5.0	2015	93.6	0	0.0	2152	100.0	137	6.4
Central Uusimaa	8294	89	1.1	416	5.0	7789	93.9	0	0.0	8294	100.0	505	6.1
City of Helsinki	27514	277	1.0	1753	6.4	25482	92.6	2	0.0	27513	100.0	2027	7.4
East Uusimaa	3909	24	0.6	179	4.6	3706	94.8	0	0.0	3909	100.0	203	5.2
Kainuu	2594	13	0.5	72	2.8	2506	96.6	3	0.1	1	0.0	0	0.0
Kanta-Häme	5814	88	1.5	361	6.2	5365	92.3	0	0.0	5814	100.0	449	7.7
Kymenlaakso	5968	63	1.1	317	5.3	5588	93.6	0	0.0	5968	100.0	380	6.4
Lapland	6825	123	1.8	485	7.1	6216	91.1	1	0.0	6493	95.1	584	9.0
North Karelia	5135	93	1.8	205	4.0	4813	93.7	24	0.5	5135	100.0	296	5.8
North Ostrobothnia	14288	146	1.0	654	4.6	13487	94.4	1	0.0	3294	23.1	218	6.6
North Savo	8367	110	1.3	530	6.3	7727	92.4	0	0.0	8281	99.0	616	7.4
Ostrobothnia	5841	80	1.4	267	4.6	5494	94.1	0	0.0	5841	100.0	347	5.9
Pirkanmaa	19198	255	1.3	1172	6.1	17768	92.6	3	0.0	19198	100.0	1427	7.4
Päijät-Häme	6817	111	1.6	423	6.2	6283	92.2	0	0.0	6717	98.5	526	7.8
Satakunta	7170	99	1.4	420	5.9	6651	92.8	0	0.0	7169	100.0	518	7.2
South Karelia	4560	59	1.3	230	5.0	4271	93.7	0	0.0	4560	100.0	289	6.3
South Ostrobothnia	7315	95	1.3	403	5.5	6817	93.2	0	0.0	7313	100.0	496	6.8
South Savo	4955	63	1.3	302	6.1	4590	92.6	0	0.0	4875	98.4	347	7.1
Southwest Finland	18823	190	1.0	1065	5.7	17564	93.3	4	0.0	17015	90.4	1131	6.6
Vantaa and Kerava	10952	139	1.3	616	5.6	10197	93.1	0	0.0	10952	100.0	755	6.9
West Uusimaa	19429	181	0.9	917	4.7	18331	94.3	0	0.0	19428	100.0	1097	5.6
Åland	1235	6	0.5	77	6.2	1152	93.3	0	0.0	1228	99.4	83	6.8
Total	206337	2445	1.2	11453	5.6	192401	93.2	38	0.0	190290	92.2	13021	6.8

Risk group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	443	198	44.7	0	0.0	245	55.3	0	0.0	437	98.6	198	45.3
Central Ostrobothnia	48	8	16.7	0	0.0	40	83.3	0	0.0	48	100.0	8	16.7
Central Uusimaa	364	175	48.1	2	0.5	186	51.1	1	0.3	364	100.0	177	48.6
City of Helsinki	1613	797	49.4	3	0.2	813	50.4	0	0.0	1613	100.0	800	49.6
East Uusimaa	183	93	50.8	0	0.0	90	49.2	0	0.0	183	100.0	93	50.8
Kainuu	38	2	5.3	4	10.5	32	84.2	0	0.0	0	0.0	0	–
Kanta-Häme	259	126	48.6	0	0.0	133	51.4	0	0.0	259	100.0	126	48.6
Kymenlaakso	340	152	44.7	0	0.0	188	55.3	0	0.0	340	100.0	152	44.7
Lapland	178	29	16.3	4	2.2	145	81.5	0	0.0	169	94.9	29	17.2
North Karelia	242	125	51.7	2	0.8	112	46.3	3	1.2	242	100.0	126	52.1
North Ostrobothnia	343	46	13.4	17	5.0	280	81.6	0	0.0	83	24.2	17	20.5
North Savo	394	205	52.0	4	1.0	185	47.0	0	0.0	394	100.0	206	52.3
Ostrobothnia	205	23	11.2	0	0.0	182	88.8	0	0.0	205	100.0	23	11.2
Pirkanmaa	898	489	54.5	0	0.0	409	45.5	0	0.0	898	100.0	489	54.5
Päijät-Häme	341	183	53.7	0	0.0	158	46.3	0	0.0	338	99.1	183	54.1
Satakunta	345	202	58.6	0	0.0	143	41.4	0	0.0	345	100.0	202	58.6
South Karelia	223	101	45.3	0	0.0	122	54.7	0	0.0	223	100.0	101	45.3
South Ostrobothnia	328	119	36.3	0	0.0	209	63.7	0	0.0	325	99.1	116	35.7
South Savo	237	16	6.8	84	35.4	137	57.8	0	0.0	232	97.9	100	43.1
Southwest Finland	789	320	40.6	0	0.0	469	59.4	0	0.0	789	100.0	320	40.6
Vantaa and Kerava	576	302	52.4	1	0.2	273	47.4	0	0.0	576	100.0	303	52.6
West Uusimaa	915	414	45.2	2	0.2	499	54.5	0	0.0	915	100.0	416	45.5
Åland	39	7	17.9	0	0.0	32	82.1	0	0.0	39	100.0	7	17.9
Total	9341	4132	44.2	123	1.3	5082	54.4	4	0.0	9017	96.5	4192	46.5

2023

Age group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	8702	131	1.5	413	4.7	8158	93.7	0	0.0	8649	99.4	543	6.3
Central Ostrobothnia	2145	27	1.3	86	4.0	2032	94.7	0	0.0	0	0.0	0	–
Central Uusimaa	8045	84	1.0	490	6.1	7471	92.9	0	0.0	8045	100.0	574	7.1
City of Helsinki	27385	333	1.2	1802	6.6	25247	92.2	3	0.0	27383	100.0	2133	7.8
East Uusimaa	3870	37	1.0	188	4.9	3644	94.2	1	0.0	3869	100.0	225	5.8
Kainuu	2464	20	0.8	72	2.9	2361	95.8	11	0.4	0	0.0	0	–
Kanta-Häme	5677	82	1.4	292	5.1	5303	93.4	0	0.0	5677	100.0	374	6.6
Kymenlaakso	5967	56	0.9	346	5.8	5565	93.3	0	0.0	5967	100.0	401	6.7
Lapland	6208	80	1.3	340	5.5	5782	93.1	6	0.1	1	0.0	0	0.0
North Karelia	4926	80	1.6	240	4.9	4592	93.2	14	0.3	4926	100.0	320	6.5
North Ostrobothnia	14068	128	0.9	550	3.9	13379	95.1	11	0.1	0	0.0	0	–
North Savo	8250	103	1.2	509	6.2	7638	92.6	0	0.0	8038	97.4	579	7.2
Ostrobothnia	6222	41	0.7	265	4.3	5910	95.0	6	0.1	0	0.0	0	–
Pirkanmaa	18603	254	1.4	1017	5.5	17332	93.2	0	0.0	18603	100.0	1271	6.8
Päijät-Häme	7055	128	1.8	433	6.1	6494	92.0	0	0.0	6938	98.3	554	8.0
Satakunta	7317	149	2.0	402	5.5	6766	92.5	0	0.0	7316	100.0	550	7.5
South Karelia	4574	54	1.2	242	5.3	4278	93.5	0	0.0	4574	100.0	296	6.5
South Ostrobothnia	7037	82	1.2	373	5.3	6581	93.5	1	0.0	6407	91.0	427	6.7
South Savo	5032	48	1.0	308	6.1	4676	92.9	0	0.0	4948	98.3	349	7.1
Southwest Finland	18617	226	1.2	1020	5.5	17344	93.2	27	0.1	15630	84.0	1015	6.5
Vantaa and Kerava	10665	124	1.2	671	6.3	9868	92.5	2	0.0	10665	100.0	794	7.4
West Uusimaa	18762	174	0.9	953	5.1	17635	94.0	0	0.0	18761	100.0	1126	6.0
Åland	1235	27	2.2	41	3.3	1165	94.3	2	0.2	0	0.0	0	–
Total	202826	2468	1.2	11053	5.4	189221	93.3	84	0.0	166397	82.0	11531	6.9

Risk group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	411	189	46.0	0	0.0	222	54.0	0	0.0	406	98.8	188	46.3
Central Ostrobothnia	63	7	11.1	6	9.5	50	79.4	0	0.0	0	0.0	0	–
Central Uusimaa	318	153	48.1	0	0.0	165	51.9	0	0.0	318	100.0	153	48.1
City of Helsinki	1230	584	47.5	4	0.3	642	52.2	0	0.0	1230	100.0	588	47.8
East Uusimaa	130	55	42.3	0	0.0	75	57.7	0	0.0	130	100.0	55	42.3
Kainuu	48	6	12.5	4	8.3	38	79.2	0	0.0	0	0.0	0	–
Kanta-Häme	249	127	51.0	0	0.0	122	49.0	0	0.0	249	100.0	127	51.0
Kymenlaakso	304	131	43.1	0	0.0	173	56.9	0	0.0	304	100.0	131	43.1
Lapland	106	19	17.9	12	11.3	75	70.8	0	0.0	0	0.0	0	–
North Karelia	279	138	49.5	2	0.7	131	47.0	8	2.9	279	100.0	140	50.2
North Ostrobothnia	293	30	10.2	32	10.9	230	78.5	1	0.3	0	0.0	0	–
North Savo	41	8	19.5	4	9.8	29	70.7	0	0.0	41	100.0	12	29.3
Ostrobothnia	222	37	16.7	11	5.0	174	78.4	0	0.0	0	0.0	0	–
Pirkanmaa	868	491	56.6	0	0.0	377	43.4	0	0.0	867	99.9	490	56.5
Päijät-Häme	301	167	55.5	0	0.0	134	44.5	0	0.0	299	99.3	167	55.9
Satakunta	386	237	61.4	0	0.0	149	38.6	0	0.0	386	100.0	237	61.4
South Karelia	57	14	24.6	0	0.0	43	75.4	0	0.0	57	100.0	14	24.6
South Ostrobothnia	288	91	31.6	2	0.7	195	67.7	0	0.0	274	95.1	92	33.6
South Savo	148	11	7.4	18	12.2	119	80.4	0	0.0	148	100.0	29	19.6
Southwest Finland	965	451	46.7	4	0.4	509	52.7	1	0.1	938	97.2	449	47.9
Vantaa and Kerava	475	239	50.3	1	0.2	235	49.5	0	0.0	475	100.0	240	50.5
West Uusimaa	686	310	45.2	0	0.0	376	54.8	0	0.0	686	100.0	310	45.2
Åland	32	2	6.2	3	9.4	27	84.4	0	0.0	0	0.0	0	–
Total	7900	3497	44.3	103	1.3	4290	54.3	10	0.1	7087	89.7	3422	48.3

2022

Age group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	9232	77	0.8	568	6.2	8584	93.0	3	0.0	8329	90.2	501	6.0
Central Ostrobothnia	2388	19	0.8	69	2.9	2296	96.1	4	0.2	0	0.0	0	–
Central Uusimaa	7849	73	0.9	368	4.7	7408	94.4	0	0.0	7849	100.0	441	5.6
City of Helsinki	26753	330	1.2	1758	6.6	24664	92.2	1	0.0	26749	100.0	2087	7.8
East Uusimaa	3856	31	0.8	182	4.7	3643	94.5	0	0.0	3856	100.0	213	5.5
Kainuu	2486	17	0.7	71	2.9	2392	96.2	6	0.2	0	0.0	0	–
Kanta-Häme	6057	47	0.8	316	5.2	5691	94.0	3	0.0	5410	89.3	350	6.5
Kymenlaakso	6007	69	1.1	370	6.2	5568	92.7	0	0.0	5958	99.2	439	7.4
Lapland	6229	62	1.0	225	3.6	5918	95.0	24	0.4	0	0.0	0	–
North Karelia	5127	69	1.3	310	6.0	4735	92.4	13	0.3	5125	100.0	378	7.4
North Ostrobothnia	14372	161	1.1	507	3.5	13670	95.1	34	0.2	1	0.0	0	0.0
North Savo	8229	85	1.0	501	6.1	7643	92.9	0	0.0	7766	94.4	565	7.3
Ostrobothnia	6164	63	1.0	270	4.4	5820	94.4	11	0.2	0	0.0	0	–
Pirkanmaa	18811	182	1.0	1094	5.8	17533	93.2	2	0.0	18809	100.0	1272	6.8
Päijät-Häme	7136	72	1.0	413	5.8	6651	93.2	0	0.0	7022	98.4	479	6.8
Satakunta	7549	73	1.0	408	5.4	7068	93.6	0	0.0	7549	100.0	481	6.4
South Karelia	4328	17	0.4	270	6.2	4041	93.4	0	0.0	4290	99.1	283	6.6
South Ostrobothnia	6716	53	0.8	345	5.1	6303	93.9	15	0.2	2738	40.8	211	7.7
South Savo	4790	48	1.0	285	5.9	4451	92.9	6	0.1	3937	82.2	245	6.2
Southwest Finland	17734	265	1.5	926	5.2	16517	93.1	26	0.1	12390	69.9	877	7.1
Vantaa and Kerava	10181	135	1.3	645	6.3	9400	92.3	1	0.0	10179	100.0	779	7.7
West Uusimaa	18495	143	0.8	997	5.4	17355	93.8	0	0.0	18493	100.0	1140	6.2
Åland	1252	26	2.1	46	3.7	1179	94.2	1	0.1	0	0.0	0	–
Total	201741	2117	1.0	10944	5.4	188530	93.5	150	0.1	156450	77.5	10741	6.9

Risk group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	467	205	43.9	18	3.9	244	52.2	0	0.0	419	89.7	196	46.8
Central Ostrobothnia	62	4	6.5	2	3.2	56	90.3	0	0.0	0	0.0	0	–
Central Uusimaa	403	201	49.9	2	0.5	200	49.6	0	0.0	403	100.0	203	50.4
City of Helsinki	1491	691	46.3	5	0.3	795	53.3	0	0.0	1490	99.9	695	46.6
East Uusimaa	192	84	43.8	3	1.6	105	54.7	0	0.0	192	100.0	87	45.3
Kainuu	35	2	5.7	2	5.7	31	88.6	0	0.0	0	0.0	0	–
Kanta-Häme	260	127	48.8	6	2.3	126	48.5	1	0.4	236	90.8	124	52.5
Kymenlaakso	96	20	20.8	0	0.0	76	79.2	0	0.0	95	99.0	20	21.1
Lapland	87	10	11.5	9	10.3	67	77.0	1	1.1	0	0.0	0	–
North Karelia	182	104	57.1	0	0.0	75	41.2	3	1.6	182	100.0	104	57.1
North Ostrobothnia	203	25	12.3	19	9.4	159	78.3	0	0.0	0	0.0	0	–
North Savo	164	4	2.4	12	7.3	148	90.2	0	0.0	159	97.0	16	10.1
Ostrobothnia	195	14	7.2	19	9.7	162	83.1	0	0.0	0	0.0	0	–
Pirkanmaa	1030	525	51.0	10	1.0	495	48.1	0	0.0	1030	100.0	514	49.9
Päijät-Häme	381	187	49.1	2	0.5	192	50.4	0	0.0	379	99.5	183	48.3
Satakunta	482	235	48.8	4	0.8	243	50.4	0	0.0	475	98.5	231	48.6
South Karelia	106	20	18.9	0	0.0	86	81.1	0	0.0	106	100.0	20	18.9
South Ostrobothnia	300	109	36.3	11	3.7	180	60.0	0	0.0	193	64.3	102	52.8
South Savo	155	16	10.3	17	11.0	121	78.1	1	0.6	119	76.8	19	16.0
Southwest Finland	711	277	39.0	22	3.1	412	57.9	0	0.0	593	83.4	263	44.4
Vantaa and Kerava	577	274	47.5	1	0.2	302	52.3	0	0.0	577	100.0	275	47.7
West Uusimaa	860	376	43.7	2	0.2	482	56.0	0	0.0	860	100.0	378	44.0
Åland	26	1	3.8	2	7.7	23	88.5	0	0.0	0	0.0	0	–
Total	8465	3511	41.5	168	2.0	4780	56.5	6	0.1	7508	88.7	3430	45.7

2021

Age group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	8068	102	1.3	570	7.1	7395	91.7	1	0.0	7271	90.1	549	7.6
Central Ostrobothnia	2020	17	0.8	76	3.8	1923	95.2	4	0.2	0	0.0	0	–
Central Uusimaa	7627	71	0.9	420	5.5	7136	93.6	0	0.0	7619	99.9	491	6.4
City of Helsinki	26570	370	1.4	1887	7.1	24313	91.5	0	0.0	26542	99.9	2254	8.5
East Uusimaa	3605	42	1.2	196	5.4	3367	93.4	0	0.0	3603	99.9	237	6.6
Kainuu	2610	19	0.7	73	2.8	2505	96.0	13	0.5	1	0.0	0	0.0
Kanta-Häme	5223	55	1.1	286	5.5	4881	93.5	1	0.0	4696	89.9	318	6.8
Kymenlaakso	6060	44	0.7	407	6.7	5609	92.6	0	0.0	6020	99.3	449	7.5
Lapland	5398	48	0.9	168	3.1	5153	95.5	29	0.5	2	0.0	0	0.0
North Karelia	4697	48	1.0	314	6.7	4327	92.1	8	0.2	4697	100.0	362	7.7
North Ostrobothnia	12518	113	0.9	480	3.8	11902	95.1	23	0.2	2	0.0	0	0.0
North Savo	7383	71	1.0	301	4.1	7010	94.9	1	0.0	23	0.3	3	13.0
Ostrobothnia	5595	43	0.8	262	4.7	5281	94.4	9	0.2	1	0.0	0	0.0
Pirkanmaa	16781	229	1.4	1083	6.5	15468	92.2	1	0.0	16769	99.9	1310	7.8
Päijät-Häme	6074	95	1.6	429	7.1	5548	91.3	2	0.0	5516	90.8	482	8.7
Satakunta	7615	102	1.3	472	6.2	7040	92.4	1	0.0	7611	99.9	574	7.5
South Karelia	3791	28	0.7	69	1.8	3693	97.4	1	0.0	1	0.0	1	100.0
South Ostrobothnia	5928	42	0.7	331	5.6	5546	93.6	9	0.2	2503	42.2	203	8.1
South Savo	3750	36	1.0	176	4.7	3536	94.3	2	0.1	2	0.1	0	0.0
Southwest Finland	16375	140	0.9	1052	6.4	15150	92.5	33	0.2	11318	69.1	911	8.0
Vantaa and Kerava	10515	144	1.4	674	6.4	9697	92.2	0	0.0	10503	99.9	817	7.8
West Uusimaa	18165	172	0.9	945	5.2	17048	93.9	0	0.0	18144	99.9	1115	6.1
Åland	1069	13	1.2	51	4.8	1003	93.8	2	0.2	1	0.1	1	100.0
Total	187437	2044	1.1	10722	5.7	174531	93.1	140	0.1	132845	70.9	10077	7.6

Risk group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	510	244	47.8	12	2.4	253	49.6	1	0.2	442	86.7	231	52.3
Central Ostrobothnia	81	1	1.2	7	8.6	73	90.1	0	0.0	0	0.0	0	–
Central Uusimaa	545	194	35.6	1	0.2	350	64.2	0	0.0	545	100.0	195	35.8
City of Helsinki	1952	707	36.2	5	0.3	1240	63.5	0	0.0	1948	99.8	711	36.5
East Uusimaa	230	90	39.1	1	0.4	139	60.4	0	0.0	230	100.0	91	39.6
Kainuu	47	2	4.3	6	12.8	39	83.0	0	0.0	0	0.0	0	–
Kanta-Häme	250	126	50.4	2	0.8	122	48.8	0	0.0	240	96.0	122	50.8
Kymenlaakso	93	18	19.4	2	2.2	73	78.5	0	0.0	89	95.7	18	20.2
Lapland	116	9	7.8	14	12.1	92	79.3	1	0.9	2	1.7	0	0.0
North Karelia	207	21	10.1	83	40.1	100	48.3	3	1.4	207	100.0	104	50.2
North Ostrobothnia	240	9	3.8	26	10.8	205	85.4	0	0.0	1	0.4	0	0.0
North Savo	110	9	8.2	23	20.9	78	70.9	0	0.0	4	3.6	0	0.0
Ostrobothnia	198	13	6.6	27	13.6	158	79.8	0	0.0	0	0.0	0	–
Pirkanmaa	1015	513	50.5	2	0.2	500	49.3	0	0.0	1015	100.0	498	49.1
Päijät-Häme	308	176	57.1	3	1.0	129	41.9	0	0.0	297	96.4	171	57.6
Satakunta	291	159	54.6	0	0.0	132	45.4	0	0.0	281	96.6	146	52.0
South Karelia	124	14	11.3	0	0.0	110	88.7	0	0.0	0	0.0	0	–
South Ostrobothnia	197	7	3.6	38	19.3	152	77.2	0	0.0	58	29.4	18	31.0
South Savo	133	4	3.0	22	16.5	107	80.5	0	0.0	1	0.8	0	0.0
Southwest Finland	704	53	7.5	200	28.4	450	63.9	1	0.1	536	76.1	221	41.2
Vantaa and Kerava	808	269	33.3	2	0.2	537	66.5	0	0.0	808	100.0	271	33.5
West Uusimaa	1110	378	34.1	3	0.3	729	65.7	0	0.0	1110	100.0	381	34.3
Åland	21	0	0.0	5	23.8	15	71.4	1	4.8	0	0.0	0	–
Total	9290	3016	32.5	484	5.2	5783	62.2	7	0.1	7814	84.1	3178	40.7

2020

Age group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	7503	66	0.9	519	6.9	6918	92.2	0	0	6749	90.0	513	7.6
Central Ostrobothnia	2017	18	0.9	70	3.5	1929	95.6	0	0	0	0.0	0	–
Central Uusimaa	7658	61	0.8	462	6.0	7134	93.2	1	0	7629	99.6	520	6.8
City of Helsinki	25531	239	0.9	1937	7.6	23351	91.5	4	0	25444	99.7	2167	8.5
East Uusimaa	3643	27	0.7	229	6.3	3387	93.0	0	0	3633	99.7	255	7.0
Kainuu	2643	13	0.5	41	1.6	2589	98.0	0	0	4	0.2	0	0.0
Kanta-Häme	4815	43	0.9	274	5.7	4498	93.4	0	0	4277	88.8	291	6.8
Kymenlaakso	6095	49	0.8	117	1.9	5929	97.3	0	0	16	0.3	2	12.5
Lapland	5370	35	0.7	100	1.9	5235	97.5	0	0	4	0.1	2	50.0
North Karelia	4946	53	1.1	291	5.9	4602	93.0	0	0	4916	99.4	344	7.0
North Ostrobothnia	12389	117	0.9	230	1.9	12042	97.2	0	0	7	0.1	2	28.6
North Savo	6917	76	1.1	145	2.1	6694	96.8	2	0	0	0.0	0	–
Ostrobothnia	5533	43	0.8	201	3.6	5288	95.6	1	0	4	0.1	0	0.0
Pirkanmaa	15621	164	1.0	1069	6.8	14388	92.1	0	0	15602	99.9	1232	7.9
Päijät-Häme	5782	46	0.8	393	6.8	5342	92.4	1	0	5153	89.1	417	8.1
Satakunta	7459	84	1.1	478	6.4	6895	92.4	2	0	7328	98.2	550	7.5
South Karelia	3714	34	0.9	116	3.1	3563	95.9	1	0	4	0.1	0	0.0
South Ostrobothnia	6146	48	0.8	367	6.0	5731	93.2	0	0	2354	38.3	230	9.8
South Savo	4166	33	0.8	231	5.5	3902	93.7	0	0	1	0.0	1	100.0
Southwest Finland	16013	161	1.0	701	4.4	15151	94.6	0	0	7718	48.2	569	7.4
Vantaa and Kerava	10113	96	0.9	715	7.1	9300	92.0	2	0	10087	99.7	810	8.0
West Uusimaa	17204	110	0.6	1046	6.1	16045	93.3	3	0	17162	99.8	1153	6.7
Åland	1105	13	1.2	30	2.7	1062	96.1	0	0	2	0.2	0	0.0
Total	182383	1629	0.9	9762	5.4	170975	93.7	17	0	118094	64.8	9058	7.7

Risk group screening

Wellbeing service county	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing		HPV tested		HPV-positive
	N	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	197	46	23.4	10	5.1	141	71.6	0	0	134	68.0	39	29.1
Central Ostrobothnia	38	1	2.6	7	18.4	30	78.9	0	0	0	0.0	0	–
City of Helsinki	1	0	0.0	0	0.0	1	100.0	0	0	1	100.0	0	0.0
East Uusimaa	1	0	0.0	0	0.0	1	100.0	0	0	1	100.0	0	0.0
Kainuu	26	0	0.0	0	0.0	26	100.0	0	0	0	0.0	0	–
Kanta-Häme	26	6	23.1	1	3.8	19	73.1	0	0	14	53.8	6	42.9
Kymenlaakso	117	17	14.5	0	0.0	100	85.5	0	0	0	0.0	0	–
Lapland	119	15	12.6	9	7.6	95	79.8	0	0	0	0.0	0	–
North Karelia	85	2	2.4	4	4.7	79	92.9	0	0	84	98.8	6	7.1
North Ostrobothnia	164	7	4.3	7	4.3	150	91.5	0	0	0	0.0	0	–
North Savo	13	2	15.4	3	23.1	8	61.5	0	0	0	0.0	0	–
Ostrobothnia	191	6	3.1	28	14.7	157	82.2	0	0	0	0.0	0	–
Pirkanmaa	89	47	52.8	0	0.0	42	47.2	0	0	89	100.0	46	51.7
Päijät-Häme	89	28	31.5	2	2.2	59	66.3	0	0	82	92.1	24	29.3
Satakunta	335	152	45.4	0	0.0	183	54.6	0	0	333	99.4	133	39.9
South Karelia	107	7	6.5	27	25.2	73	68.2	0	0	0	0.0	0	–
South Ostrobothnia	242	8	3.3	42	17.4	192	79.3	0	0	129	53.3	28	21.7
South Savo	56	0	0.0	4	7.1	52	92.9	0	0	0	0.0	0	–
Southwest Finland	645	37	5.7	151	23.4	457	70.9	0	0	413	64.0	161	39.0
Åland	11	0	0.0	3	27.3	8	72.7	0	0	0	0.0	0	–
Total	2552	381	14.9	298	11.7	1873	73.4	0	0	1280	50.2	443	34.6

Histological findings

Proportion of referred

2024

Age group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	111	0	0.0	1	0.9	31	27.9	50	45.0	3	2.7	6	5.4	20	18.0
Central Ostrobothnia	30	1	3.3	2	6.7	9	30.0	10	33.3	5	16.7	1	3.3	2	6.7
Central Uusimaa	89	1	1.1	1	1.1	32	36.0	39	43.8	14	15.7	0	0.0	2	2.2
City of Helsinki	277	2	0.7	5	1.8	98	35.4	46	16.6	109	39.4	0	0.0	17	6.1
East Uusimaa	24	1	4.2	1	4.2	7	29.2	9	37.5	5	20.8	0	0.0	1	4.2
Kainuu	13	1	7.7	0	0.0	5	38.5	1	7.7	3	23.1	0	0.0	3	23.1
Kanta-Häme	88	2	2.3	0	0.0	28	31.8	21	23.9	28	31.8	1	1.1	8	9.1
Kymenlaakso	63	2	3.2	0	0.0	22	34.9	13	20.6	20	31.7	0	0.0	6	9.5
Lapland	123	0	0.0	1	0.8	33	26.8	35	28.5	28	22.8	3	2.4	23	18.7
North Karelia	93	2	2.2	2	2.2	33	35.5	40	43.0	12	12.9	2	2.2	2	2.2
North Ostrobothnia	146	2	1.4	2	1.4	50	34.2	11	7.5	40	27.4	2	1.4	39	26.7
North Savo	110	2	1.8	2	1.8	36	32.7	36	32.7	25	22.7	5	4.5	4	3.6
Ostrobothnia	80	2	2.5	3	3.8	28	35.0	27	33.8	15	18.8	3	3.8	2	2.5
Pirkanmaa	255	2	0.8	4	1.6	79	31.0	67	26.3	85	33.3	5	2.0	13	5.1
Päijät-Häme	111	2	1.8	3	2.7	33	29.7	30	27.0	36	32.4	3	2.7	4	3.6
Satakunta	99	0	0.0	2	2.0	32	32.3	25	25.3	33	33.3	5	5.1	2	2.0
South Karelia	59	2	3.4	0	0.0	18	30.5	13	22.0	15	25.4	1	1.7	10	16.9
South Ostrobothnia	95	0	0.0	0	0.0	38	40.0	29	30.5	21	22.1	1	1.1	6	6.3
South Savo	63	1	1.6	0	0.0	22	34.9	24	38.1	10	15.9	0	0.0	6	9.5
Southwest Finland	190	0	0.0	0	0.0	2	1.1	2	1.1	0	0.0	0	0.0	186	97.9
Vantaa and Kerava	139	1	0.7	2	1.4	48	34.5	41	29.5	42	30.2	0	0.0	5	3.6
West Uusimaa	181	1	0.6	2	1.1	52	28.7	43	23.8	73	40.3	3	1.7	7	3.9
Åland	6	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	6	100.0
Total	2445	27	1.1	33	1.3	736	30.1	612	25.0	622	25.4	41	1.7	374	15.3

Risk group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	198	0	0.0	1	0.5	23	11.6	110	55.6	10	5.1	21	10.6	33	16.7
Central Ostrobothnia	8	0	0.0	0	0.0	2	25.0	1	12.5	2	25.0	0	0.0	3	37.5
Central Uusimaa	175	2	1.1	3	1.7	57	32.6	55	31.4	52	29.7	1	0.6	5	2.9
City of Helsinki	797	3	0.4	6	0.8	137	17.2	182	22.8	414	51.9	6	0.8	49	6.1
East Uusimaa	93	2	2.2	1	1.1	29	31.2	38	40.9	21	22.6	0	0.0	2	2.2
Kainuu	2	0	0.0	0	0.0	1	50.0	0	0.0	1	50.0	0	0.0	0	0.0
Kanta-Häme	126	0	0.0	1	0.8	18	14.3	26	20.6	62	49.2	1	0.8	18	14.3
Kymenlaakso	152	1	0.7	2	1.3	24	15.8	27	17.8	90	59.2	0	0.0	8	5.3
Lapland	29	0	0.0	0	0.0	5	17.2	7	24.1	11	37.9	1	3.4	5	17.2
North Karelia	125	0	0.0	0	0.0	19	15.2	77	61.6	22	17.6	3	2.4	4	3.2
North Ostrobothnia	46	0	0.0	0	0.0	11	23.9	7	15.2	22	47.8	1	2.2	5	10.9
North Savo	205	1	0.5	0	0.0	33	16.1	72	35.1	69	33.7	12	5.9	18	8.8
Ostrobothnia	23	0	0.0	0	0.0	10	43.5	9	39.1	2	8.7	1	4.3	1	4.3
Pirkanmaa	489	1	0.2	4	0.8	81	16.6	86	17.6	248	50.7	17	3.5	52	10.6
Päijät-Häme	183	1	0.5	1	0.5	26	14.2	36	19.7	95	51.9	10	5.5	14	7.7
Satakunta	202	0	0.0	2	1.0	34	16.8	28	13.9	95	47.0	38	18.8	5	2.5
South Karelia	101	0	0.0	0	0.0	11	10.9	35	34.7	38	37.6	1	1.0	16	15.8
South Ostrobothnia	119	0	0.0	0	0.0	22	18.5	25	21.0	54	45.4	5	4.2	13	10.9
South Savo	16	0	0.0	0	0.0	5	31.2	9	56.2	2	12.5	0	0.0	0	0.0
Southwest Finland	320	0	0.0	0	0.0	0	0.0	1	0.3	0	0.0	0	0.0	319	99.7
Vantaa and Kerava	302	2	0.7	1	0.3	42	13.9	77	25.5	158	52.3	2	0.7	20	6.6
West Uusimaa	414	3	0.7	4	1.0	63	15.2	111	26.8	207	50.0	8	1.9	18	4.3
Åland	7	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	7	100.0
Total	4132	16	0.4	26	0.6	653	15.8	1019	24.7	1675	40.5	128	3.1	615	14.9

2023

Age group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	131	2	1.5	0	0.0	36	27.5	76	58.0	4	3.1	7	5.3	6	4.6
Central Ostrobothnia	27	0	0.0	1	3.7	11	40.7	6	22.2	8	29.6	1	3.7	0	0.0
Central Uusimaa	84	3	3.6	1	1.2	34	40.5	31	36.9	11	13.1	0	0.0	4	4.8
City of Helsinki	333	5	1.5	3	0.9	105	31.5	97	29.1	101	30.3	0	0.0	22	6.6
East Uusimaa	37	2	5.4	0	0.0	15	40.5	10	27.0	9	24.3	0	0.0	1	2.7
Kainuu	20	0	0.0	0	0.0	1	5.0	2	10.0	9	45.0	0	0.0	8	40.0
Kanta-Häme	82	0	0.0	3	3.7	25	30.5	27	32.9	23	28.0	1	1.2	3	3.7
Kymenlaakso	56	0	0.0	0	0.0	22	39.3	12	21.4	19	33.9	0	0.0	3	5.4
Lapland	80	1	1.2	2	2.5	23	28.7	17	21.2	20	25.0	0	0.0	17	21.2
North Karelia	80	0	0.0	2	2.5	37	46.2	33	41.2	3	3.8	2	2.5	3	3.8
North Ostrobothnia	128	1	0.8	3	2.3	39	30.5	10	7.8	60	46.9	5	3.9	10	7.8
North Savo	103	0	0.0	0	0.0	38	36.9	33	32.0	25	24.3	3	2.9	4	3.9
Ostrobothnia	41	0	0.0	0	0.0	15	36.6	8	19.5	9	22.0	5	12.2	4	9.8
Pirkanmaa	254	3	1.2	3	1.2	94	37.0	66	26.0	74	29.1	8	3.1	6	2.4
Päijät-Häme	128	0	0.0	3	2.3	37	28.9	25	19.5	49	38.3	7	5.5	7	5.5
Satakunta	149	2	1.3	4	2.7	51	34.2	28	18.8	54	36.2	8	5.4	2	1.3
South Karelia	54	0	0.0	0	0.0	5	9.3	33	61.1	14	25.9	1	1.9	1	1.9
South Ostrobothnia	82	1	1.2	2	2.4	37	45.1	25	30.5	14	17.1	1	1.2	2	2.4
South Savo	48	2	4.2	0	0.0	24	50.0	13	27.1	8	16.7	0	0.0	1	2.1
Southwest Finland	226	3	1.3	5	2.2	84	37.2	14	6.2	18	8.0	0	0.0	102	45.1
Vantaa and Kerava	124	4	3.2	2	1.6	43	34.7	33	26.6	41	33.1	0	0.0	1	0.8
West Uusimaa	174	1	0.6	2	1.1	63	36.2	55	31.6	47	27.0	0	0.0	6	3.4
Åland	27	1	3.7	0	0.0	8	29.6	3	11.1	14	51.9	0	0.0	1	3.7
Total	2468	31	1.3	36	1.5	847	34.3	657	26.6	634	25.7	49	2.0	214	8.7

Risk group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	189	0	0.0	1	0.5	26	13.8	125	66.1	14	7.4	17	9.0	6	3.2
Central Ostrobothnia	7	0	0.0	0	0.0	0	0.0	1	14.3	6	85.7	0	0.0	0	0.0
Central Uusimaa	153	2	1.3	0	0.0	41	26.8	57	37.3	46	30.1	1	0.7	6	3.9
City of Helsinki	584	3	0.5	3	0.5	98	16.8	170	29.1	276	47.3	7	1.2	27	4.6
East Uusimaa	55	0	0.0	1	1.8	16	29.1	15	27.3	22	40.0	0	0.0	1	1.8
Kainuu	6	0	0.0	0	0.0	1	16.7	2	33.3	3	50.0	0	0.0	0	0.0
Kanta-Häme	127	0	0.0	1	0.8	21	16.5	35	27.6	52	40.9	9	7.1	9	7.1
Kymenlaakso	131	1	0.8	2	1.5	11	8.4	23	17.6	90	68.7	1	0.8	3	2.3
Lapland	19	0	0.0	0	0.0	6	31.6	5	26.3	7	36.8	0	0.0	1	5.3
North Karelia	138	1	0.7	1	0.7	26	18.8	66	47.8	36	26.1	3	2.2	5	3.6
North Ostrobothnia	30	0	0.0	0	0.0	4	13.3	1	3.3	20	66.7	0	0.0	5	16.7
North Savo	8	0	0.0	0	0.0	1	12.5	2	25.0	4	50.0	1	12.5	0	0.0
Ostrobothnia	37	0	0.0	0	0.0	7	18.9	5	13.5	12	32.4	9	24.3	4	10.8
Pirkanmaa	491	2	0.4	3	0.6	99	20.2	111	22.6	224	45.6	37	7.5	15	3.1
Päijät-Häme	167	0	0.0	0	0.0	40	24.0	25	15.0	89	53.3	9	5.4	4	2.4
Satakunta	237	2	0.8	2	0.8	47	19.8	36	15.2	114	48.1	34	14.3	2	0.8
South Karelia	14	0	0.0	0	0.0	3	21.4	8	57.1	1	7.1	0	0.0	2	14.3
South Ostrobothnia	91	0	0.0	1	1.1	21	23.1	18	19.8	40	44.0	4	4.4	7	7.7
South Savo	11	0	0.0	0	0.0	5	45.5	4	36.4	2	18.2	0	0.0	0	0.0
Southwest Finland	451	1	0.2	1	0.2	98	21.7	6	1.3	4	0.9	0	0.0	341	75.6
Vantaa and Kerava	239	2	0.8	0	0.0	43	18.0	65	27.2	121	50.6	2	0.8	6	2.5
West Uusimaa	310	1	0.3	5	1.6	61	19.7	69	22.3	157	50.6	4	1.3	13	4.2
Åland	2	0	0.0	0	0.0	1	50.0	0	0.0	1	50.0	0	0.0	0	0.0
Total	3497	15	0.4	21	0.6	676	19.3	849	24.3	1341	38.3	138	3.9	457	13.1

2022

Age group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	77	0	0.0	0	0.0	27	35.1	37	48.1	2	2.6	10	13.0	1	1.3
Central Ostrobothnia	19	2	10.5	1	5.3	4	21.1	4	21.1	8	42.1	0	0.0	0	0.0
Central Uusimaa	73	0	0.0	0	0.0	33	45.2	31	42.5	7	9.6	0	0.0	2	2.7
City of Helsinki	330	4	1.2	8	2.4	120	36.4	92	27.9	96	29.1	1	0.3	9	2.7
East Uusimaa	31	0	0.0	0	0.0	12	38.7	12	38.7	7	22.6	0	0.0	0	0.0
Kainuu	17	0	0.0	0	0.0	7	41.2	4	23.5	6	35.3	0	0.0	0	0.0
Kanta-Häme	47	0	0.0	2	4.3	18	38.3	12	25.5	10	21.3	3	6.4	2	4.3
Kymenlaakso	69	0	0.0	0	0.0	27	39.1	13	18.8	27	39.1	0	0.0	2	2.9
Lapland	62	1	1.6	0	0.0	21	33.9	23	37.1	13	21.0	2	3.2	2	3.2
North Karelia	69	0	0.0	3	4.3	26	37.7	26	37.7	11	15.9	1	1.4	2	2.9
North Ostrobothnia	161	3	1.9	1	0.6	56	34.8	31	19.3	48	29.8	2	1.2	20	12.4
North Savo	85	0	0.0	4	4.7	29	34.1	26	30.6	22	25.9	3	3.5	1	1.2
Ostrobothnia	63	0	0.0	1	1.6	28	44.4	13	20.6	19	30.2	2	3.2	0	0.0
Pirkanmaa	182	0	0.0	3	1.6	90	49.5	38	20.9	43	23.6	4	2.2	4	2.2
Päijät-Häme	72	4	5.6	1	1.4	43	59.7	5	6.9	18	25.0	0	0.0	1	1.4
Satakunta	73	0	0.0	2	2.7	27	37.0	8	11.0	21	28.8	14	19.2	1	1.4
South Karelia	17	0	0.0	0	0.0	2	11.8	10	58.8	5	29.4	0	0.0	0	0.0
South Ostrobothnia	53	1	1.9	2	3.8	18	34.0	16	30.2	15	28.3	1	1.9	0	0.0
South Savo	48	0	0.0	1	2.1	16	33.3	25	52.1	6	12.5	0	0.0	0	0.0
Southwest Finland	265	3	1.1	5	1.9	101	38.1	70	26.4	72	27.2	7	2.6	7	2.6
Vantaa and Kerava	135	1	0.7	2	1.5	51	37.8	40	29.6	34	25.2	2	1.5	5	3.7
West Uusimaa	143	0	0.0	4	2.8	56	39.2	37	25.9	37	25.9	2	1.4	7	4.9
Åland	26	1	3.8	0	0.0	4	15.4	7	26.9	12	46.2	1	3.8	1	3.8
Total	2117	20	0.9	40	1.9	816	38.5	580	27.4	539	25.5	55	2.6	67	3.2

Risk group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	205	1	0.5	0	0.0	33	16.1	126	61.5	18	8.8	19	9.3	8	3.9
Central Ostrobothnia	4	0	0.0	0	0.0	1	25.0	1	25.0	1	25.0	1	25.0	0	0.0
Central Uusimaa	201	1	0.5	2	1.0	61	30.3	78	38.8	49	24.4	2	1.0	8	4.0
City of Helsinki	691	5	0.7	12	1.7	141	20.4	184	26.6	314	45.4	9	1.3	26	3.8
East Uusimaa	84	0	0.0	1	1.2	15	17.9	24	28.6	37	44.0	1	1.2	6	7.1
Kainuu	2	0	0.0	0	0.0	2	100.0	0	0.0	0	0.0	0	0.0	0	0.0
Kanta-Häme	127	0	0.0	1	0.8	26	20.5	27	21.3	58	45.7	8	6.3	7	5.5
Kymenlaakso	20	0	0.0	0	0.0	4	20.0	6	30.0	9	45.0	0	0.0	1	5.0
Lapland	10	0	0.0	0	0.0	8	80.0	2	20.0	0	0.0	0	0.0	0	0.0
North Karelia	104	0	0.0	2	1.9	13	12.5	52	50.0	31	29.8	5	4.8	1	1.0
North Ostrobothnia	25	0	0.0	0	0.0	6	24.0	4	16.0	13	52.0	1	4.0	1	4.0
North Savo	4	0	0.0	0	0.0	1	25.0	1	25.0	2	50.0	0	0.0	0	0.0
Ostrobothnia	14	0	0.0	0	0.0	1	7.1	6	42.9	6	42.9	1	7.1	0	0.0
Pirkanmaa	525	0	0.0	5	1.0	126	24.0	100	19.0	244	46.5	30	5.7	20	3.8
Päijät-Häme	187	0	0.0	5	2.7	49	26.2	41	21.9	81	43.3	8	4.3	3	1.6
Satakunta	235	2	0.9	0	0.0	44	18.7	34	14.5	110	46.8	42	17.9	3	1.3
South Karelia	20	0	0.0	0	0.0	4	20.0	8	40.0	6	30.0	0	0.0	2	10.0
South Ostrobothnia	109	0	0.0	0	0.0	18	16.5	26	23.9	40	36.7	16	14.7	9	8.3
South Savo	16	0	0.0	0	0.0	3	18.8	9	56.2	3	18.8	0	0.0	1	6.2
Southwest Finland	277	0	0.0	5	1.8	68	24.5	61	22.0	119	43.0	11	4.0	13	4.7
Vantaa and Kerava	274	1	0.4	3	1.1	58	21.2	75	27.4	124	45.3	3	1.1	10	3.6
West Uusimaa	376	1	0.3	3	0.8	73	19.4	109	29.0	173	46.0	2	0.5	15	4.0
Åland	1	0	0.0	0	0.0	0	0.0	1	100.0	0	0.0	0	0.0	0	0.0
Total	3511	11	0.3	39	1.1	755	21.5	975	27.8	1438	41.0	159	4.5	134	3.8

2021

Age group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	102	2	2.0	1	1.0	42	41.2	45	44.1	8	7.8	4	3.9	0	0.0
Central Ostrobothnia	17	0	0.0	0	0.0	6	35.3	1	5.9	2	11.8	1	5.9	7	41.2
Central Uusimaa	71	1	1.4	0	0.0	41	57.7	19	26.8	9	12.7	0	0.0	1	1.4
City of Helsinki	370	5	1.4	7	1.9	141	38.1	93	25.1	110	29.7	0	0.0	14	3.8
East Uusimaa	42	0	0.0	0	0.0	20	47.6	16	38.1	5	11.9	0	0.0	1	2.4
Kainuu	19	0	0.0	1	5.3	4	21.1	4	21.1	2	10.5	0	0.0	8	42.1
Kanta-Häme	55	2	3.6	1	1.8	24	43.6	16	29.1	8	14.5	1	1.8	3	5.5
Kymenlaakso	44	1	2.3	0	0.0	24	54.5	7	15.9	11	25.0	0	0.0	1	2.3
Lapland	48	0	0.0	0	0.0	23	47.9	12	25.0	3	6.2	2	4.2	8	16.7
North Karelia	48	1	2.1	0	0.0	16	33.3	5	10.4	10	20.8	1	2.1	15	31.2
North Ostrobothnia	113	2	1.8	0	0.0	35	31.0	14	12.4	13	11.5	0	0.0	49	43.4
North Savo	71	4	5.6	0	0.0	23	32.4	12	16.9	19	26.8	2	2.8	11	15.5
Ostrobothnia	43	0	0.0	0	0.0	13	30.2	9	20.9	14	32.6	0	0.0	7	16.3
Pirkanmaa	229	6	2.6	6	2.6	84	36.7	53	23.1	63	27.5	17	7.4	0	0.0
Päijät-Häme	95	3	3.2	1	1.1	45	47.4	13	13.7	25	26.3	3	3.2	5	5.3
Satakunta	102	0	0.0	4	3.9	57	55.9	20	19.6	14	13.7	7	6.9	0	0.0
South Karelia	28	0	0.0	0	0.0	8	28.6	9	32.1	11	39.3	0	0.0	0	0.0
South Ostrobothnia	42	0	0.0	0	0.0	23	54.8	8	19.0	5	11.9	4	9.5	2	4.8
South Savo	36	1	2.8	1	2.8	9	25.0	18	50.0	5	13.9	1	2.8	1	2.8
Southwest Finland	140	3	2.1	2	1.4	60	42.9	25	17.9	19	13.6	1	0.7	30	21.4
Vantaa and Kerava	144	4	2.8	3	2.1	61	42.4	39	27.1	33	22.9	0	0.0	4	2.8
West Uusimaa	172	3	1.7	1	0.6	70	40.7	56	32.6	34	19.8	2	1.2	6	3.5
Åland	13	0	0.0	1	7.7	4	30.8	0	0.0	2	15.4	0	0.0	6	46.2
Total	2044	38	1.9	29	1.4	833	40.8	494	24.2	425	20.8	46	2.3	179	8.8

Risk group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	244	0	0.0	1	0.4	52	21.3	145	59.4	30	12.3	16	6.6	0	0.0
Central Ostrobothnia	1	0	0.0	0	0.0	0	0.0	0	0.0	1	100.0	0	0.0	0	0.0
Central Uusimaa	194	0	0.0	1	0.5	44	22.7	81	41.8	59	30.4	0	0.0	9	4.6
City of Helsinki	707	3	0.4	8	1.1	143	20.2	184	26.0	334	47.2	2	0.3	33	4.7
East Uusimaa	90	0	0.0	2	2.2	23	25.6	33	36.7	27	30.0	2	2.2	3	3.3
Kainuu	2	0	0.0	0	0.0	1	50.0	0	0.0	0	0.0	0	0.0	1	50.0
Kanta-Häme	126	0	0.0	0	0.0	26	20.6	39	31.0	49	38.9	12	9.5	0	0.0
Kymenlaakso	18	0	0.0	0	0.0	5	27.8	2	11.1	10	55.6	0	0.0	1	5.6
Lapland	9	0	0.0	0	0.0	4	44.4	1	11.1	3	33.3	1	11.1	0	0.0
North Karelia	21	0	0.0	1	4.8	4	19.0	4	19.0	5	23.8	0	0.0	7	33.3
North Ostrobothnia	9	1	11.1	1	11.1	0	0.0	1	11.1	1	11.1	0	0.0	5	55.6
North Savo	9	0	0.0	1	11.1	3	33.3	2	22.2	1	11.1	0	0.0	2	22.2
Ostrobothnia	13	0	0.0	0	0.0	4	30.8	2	15.4	4	30.8	1	7.7	2	15.4
Pirkanmaa	513	3	0.6	4	0.8	93	18.1	103	20.1	243	47.4	67	13.1	0	0.0
Päijät-Häme	176	2	1.1	1	0.6	39	22.2	33	18.8	88	50.0	12	6.8	1	0.6
Satakunta	159	0	0.0	2	1.3	22	13.8	39	24.5	73	45.9	23	14.5	0	0.0
South Karelia	14	0	0.0	0	0.0	3	21.4	3	21.4	6	42.9	0	0.0	2	14.3
South Ostrobothnia	7	0	0.0	0	0.0	2	28.6	3	42.9	0	0.0	0	0.0	2	28.6
South Savo	4	0	0.0	0	0.0	3	75.0	0	0.0	1	25.0	0	0.0	0	0.0
Southwest Finland	53	1	1.9	1	1.9	23	43.4	3	5.7	5	9.4	0	0.0	20	37.7
Vantaa and Kerava	269	0	0.0	3	1.1	61	22.7	82	30.5	110	40.9	2	0.7	11	4.1
West Uusimaa	378	3	0.8	4	1.1	82	21.7	93	24.6	179	47.4	5	1.3	12	3.2
Åland	0	0	–	0	–	0	–	0	–	0	–	0	–	0	–
Total	3016	13	0.4	30	1.0	637	21.1	853	28.3	1229	40.7	143	4.7	111	3.7

2020

Age group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	66	0	0.0	1	1.5	24	36.4	34	51.5	4	6.1	3	4.5	0	0.0
Central Ostrobothnia	18	0	0.0	0	0.0	5	27.8	6	33.3	7	38.9	0	0.0	0	0.0
Central Uusimaa	61	2	3.3	1	1.6	39	63.9	13	21.3	6	9.8	0	0.0	0	0.0
City of Helsinki	239	3	1.3	6	2.5	96	40.2	63	26.4	60	25.1	0	0.0	11	4.6
East Uusimaa	27	1	3.7	0	0.0	15	55.6	9	33.3	1	3.7	1	3.7	0	0.0
Kainuu	13	0	0.0	0	0.0	3	23.1	3	23.1	7	53.8	0	0.0	0	0.0
Kanta-Häme	43	1	2.3	0	0.0	9	20.9	6	14.0	9	20.9	18	41.9	0	0.0
Kymenlaakso	49	1	2.0	1	2.0	23	46.9	7	14.3	17	34.7	0	0.0	0	0.0
Lapland	35	0	0.0	2	5.7	18	51.4	6	17.1	5	14.3	4	11.4	0	0.0
North Karelia	53	0	0.0	5	9.4	21	39.6	11	20.8	3	5.7	13	24.5	0	0.0
North Ostrobothnia	117	1	0.9	0	0.0	56	47.9	21	17.9	27	23.1	12	10.3	0	0.0
North Savo	76	0	0.0	0	0.0	28	36.8	16	21.1	24	31.6	8	10.5	0	0.0
Ostrobothnia	43	1	2.3	0	0.0	17	39.5	17	39.5	8	18.6	0	0.0	0	0.0
Pirkanmaa	164	1	0.6	5	3.0	80	48.8	25	15.2	39	23.8	14	8.5	0	0.0
Päijät-Häme	46	0	0.0	0	0.0	19	41.3	10	21.7	12	26.1	5	10.9	0	0.0
Satakunta	84	0	0.0	2	2.4	37	44.0	13	15.5	29	34.5	3	3.6	0	0.0
South Karelia	34	1	2.9	1	2.9	13	38.2	6	17.6	10	29.4	3	8.8	0	0.0
South Ostrobothnia	48	1	2.1	1	2.1	26	54.2	13	27.1	5	10.4	2	4.2	0	0.0
South Savo	33	1	3.0	0	0.0	18	54.5	7	21.2	3	9.1	4	12.1	0	0.0
Southwest Finland	161	4	2.5	5	3.1	73	45.3	22	13.7	20	12.4	37	23.0	0	0.0
Vantaa and Kerava	96	4	4.2	2	2.1	42	43.8	18	18.8	26	27.1	1	1.0	3	3.1
West Uusimaa	110	5	4.5	4	3.6	51	46.4	23	20.9	25	22.7	0	0.0	2	1.8
Åland	13	0	0.0	0	0.0	4	30.8	4	30.8	4	30.8	1	7.7	0	0.0
Total	1629	27	1.7	36	2.2	717	44.0	353	21.7	351	21.5	129	7.9	16	1.0

Risk group screening

Wellbeing service county	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Central Finland	46	0	0.0	0	0.0	7	15.2	26	56.5	6	13.0	7	15.2	0	0.0
Central Ostrobothnia	1	0	0.0	0	0.0	1	100.0	0	0.0	0	0.0	0	0.0	0	0.0
City of Helsinki	0	0	–	0	–	0	–	0	–	0	–	0	–	0	–
East Uusimaa	0	0	–	0	–	0	–	0	–	0	–	0	–	0	–
Kainuu	0	0	–	0	–	0	–	0	–	0	–	0	–	0	–
Kanta-Häme	6	0	0.0	0	0.0	0	0.0	2	33.3	3	50.0	1	16.7	0	0.0
Kymenlaakso	17	0	0.0	0	0.0	4	23.5	2	11.8	11	64.7	0	0.0	0	0.0
Lapland	15	1	6.7	0	0.0	10	66.7	0	0.0	1	6.7	2	13.3	1	6.7
North Karelia	2	0	0.0	0	0.0	0	0.0	2	100.0	0	0.0	0	0.0	0	0.0
North Ostrobothnia	7	0	0.0	1	14.3	3	42.9	1	14.3	1	14.3	1	14.3	0	0.0
North Savo	2	0	0.0	0	0.0	0	0.0	0	0.0	1	50.0	1	50.0	0	0.0
Ostrobothnia	6	0	0.0	0	0.0	2	33.3	2	33.3	2	33.3	0	0.0	0	0.0
Pirkanmaa	47	0	0.0	0	0.0	8	17.0	14	29.8	17	36.2	8	17.0	0	0.0
Päijät-Häme	28	0	0.0	0	0.0	8	28.6	6	21.4	7	25.0	7	25.0	0	0.0
Satakunta	152	0	0.0	0	0.0	33	21.7	26	17.1	60	39.5	33	21.7	0	0.0
South Karelia	7	0	0.0	0	0.0	4	57.1	3	42.9	0	0.0	0	0.0	0	0.0
South Ostrobothnia	8	0	0.0	0	0.0	6	75.0	0	0.0	2	25.0	0	0.0	0	0.0
South Savo	0	0	–	0	–	0	–	0	–	0	–	0	–	0	–
Southwest Finland	37	1	2.7	2	5.4	17	45.9	6	16.2	6	16.2	5	13.5	0	0.0
Åland	0	0	–	0	–	0	–	0	–	0	–	0	–	0	–
Total	381	2	0.5	3	0.8	103	27.0	90	23.6	117	30.7	65	17.1	1	0.3

Delays in access to colposcopy

2024

2023

2022

2021

2020

Test method

Screening results

Proportion of attended

2024

Age group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	16047	167	1.0	676	4.2	15198	94.7	6	0
HPV test	190290	2278	1.2	10777	5.7	177203	93.1	32	0
Total	206337	2445	1.2	11453	5.6	192401	93.2	38	0

Risk group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	324	34	10.5	25	7.7	265	81.8	0	0
HPV test	9017	4098	45.4	98	1.1	4817	53.4	4	0
Total	9341	4132	44.2	123	1.3	5082	54.4	4	0

2023

Age group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	36429	416	1.1	1557	4.3	34413	94.5	43	0.1
HPV test	166397	2052	1.2	9496	5.7	154808	93.0	41	0.0
Total	202826	2468	1.2	11053	5.4	189221	93.3	84	0.0

Risk group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	813	108	13.3	70	8.6	634	78.0	1	0.1
HPV test	7087	3389	47.8	33	0.5	3656	51.6	9	0.1
Total	7900	3497	44.3	103	1.3	4290	54.3	10	0.1

2022

Age group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	45291	502	1.1	1810	4.0	42867	94.6	112	0.2
HPV test	156450	1615	1.0	9134	5.8	145663	93.1	38	0.0
Total	201741	2117	1.0	10944	5.4	188530	93.5	150	0.1

Risk group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	957	88	9.2	112	11.7	755	78.9	2	0.2
HPV test	7508	3423	45.6	56	0.7	4025	53.6	4	0.1
Total	8465	3511	41.5	168	2.0	4780	56.5	6	0.1

2021

Age group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	54592	469	0.9	2216	4.1	51788	94.9	119	0.2
HPV test	132845	1575	1.2	8506	6.4	122743	92.4	21	0.0
Total	187437	2044	1.1	10722	5.7	174531	93.1	140	0.1

Risk group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	1476	79	5.4	195	13.2	1198	81.2	4	0.3
HPV test	7814	2937	37.6	289	3.7	4585	58.7	3	0.0
Total	9290	3016	32.5	484	5.2	5783	62.2	7	0.1

2020

Age group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	64289	564	0.9	1764	2.7	61954	96.4	7	0
HPV test	118094	1065	0.9	7998	6.8	109021	92.3	10	0
Total	182383	1629	0.9	9762	5.4	170975	93.7	17	0

Risk group screening

Test type	Attended	Referral to colposcopy		Follow-up recommendation		Normal result		Inadequate/missing
	N	N	%	N	%	N	%	N	%
Pap test	1272	70	5.5	137	10.8	1065	83.7	0	0
HPV test	1280	311	24.3	161	12.6	808	63.1	0	0
Total	2552	381	14.9	298	11.7	1873	73.4	0	0

Histological findings

Proportion of referred

2024

Age group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	167	3	1.8	1	0.6	43	25.7	10	6.0	36	21.6	0	0.0	74	44.3
HPV test	2278	24	1.1	32	1.4	693	30.4	602	26.4	586	25.7	41	1.8	300	13.2
Total	2445	27	1.1	33	1.3	736	30.1	612	25.0	622	25.4	41	1.7	374	15.3

Risk group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	34	0	0.0	0	0.0	7	20.6	5	14.7	18	52.9	0	0.0	4	11.8
HPV test	4098	16	0.4	26	0.6	646	15.8	1014	24.7	1657	40.4	128	3.1	611	14.9
Total	4132	16	0.4	26	0.6	653	15.8	1019	24.7	1675	40.5	128	3.1	615	14.9

2023

Age group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	416	4	1.0	7	1.7	125	30.0	56	13.5	140	33.7	11	2.6	73	17.5
HPV test	2052	27	1.3	29	1.4	722	35.2	601	29.3	494	24.1	38	1.9	141	6.9
Total	2468	31	1.3	36	1.5	847	34.3	657	26.6	634	25.7	49	2.0	214	8.7

Risk group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	108	0	0.0	0	0.0	20	18.5	16	14.8	52	48.1	10	9.3	10	9.3
HPV test	3389	15	0.4	21	0.6	656	19.4	833	24.6	1289	38.0	128	3.8	447	13.2
Total	3497	15	0.4	21	0.6	676	19.3	849	24.3	1341	38.3	138	3.9	457	13.1

2022

Age group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	502	8	1.6	7	1.4	173	34.5	126	25.1	149	29.7	11	2.2	28	5.6
HPV test	1615	12	0.7	33	2.0	643	39.8	454	28.1	390	24.1	44	2.7	39	2.4
Total	2117	20	0.9	40	1.9	816	38.5	580	27.4	539	25.5	55	2.6	67	3.2

Risk group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	88	0	0.0	1	1.1	22	25.0	22	25.0	38	43.2	3	3.4	2	2.3
HPV test	3423	11	0.3	38	1.1	733	21.4	953	27.8	1400	40.9	156	4.6	132	3.9
Total	3511	11	0.3	39	1.1	755	21.5	975	27.8	1438	41.0	159	4.5	134	3.8

2021

Age group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	469	8	1.7	5	1.1	153	32.6	100	21.3	84	17.9	8	1.7	111	23.7
HPV test	1575	30	1.9	24	1.5	680	43.2	394	25.0	341	21.7	38	2.4	68	4.3
Total	2044	38	1.9	29	1.4	833	40.8	494	24.2	425	20.8	46	2.3	179	8.8

Risk group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	79	1	1.3	3	3.8	26	32.9	12	15.2	18	22.8	4	5.1	15	19.0
HPV test	2937	12	0.4	27	0.9	611	20.8	841	28.6	1211	41.2	139	4.7	96	3.3
Total	3016	13	0.4	30	1.0	637	21.1	853	28.3	1229	40.7	143	4.7	111	3.7

2020

Age group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	564	8	1.4	7	1.2	235	41.7	123	21.8	128	22.7	63	11.2	0	0.0
HPV test	1065	19	1.8	29	2.7	482	45.3	230	21.6	223	20.9	66	6.2	16	1.5
Total	1629	27	1.7	36	2.2	717	44.0	353	21.7	351	21.5	129	7.9	16	1.0

Risk group screening

Test type	Referral to colposcopy	Cervical cancer		AIS		HSIL		LSIL		Normal/benign		Other/ unknown		No further examinations
	N	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Pap test	70	1	1.4	2	2.9	32	45.7	9	12.9	17	24.3	8	11.4	1	1.4
HPV test	311	1	0.3	1	0.3	71	22.8	81	26.0	100	32.2	57	18.3	0	0.0
Total	381	2	0.5	3	0.8	103	27.0	90	23.6	117	30.7	65	17.1	1	0.3

Delays in access to colposcopy

2024

2023

2022

2021

2020

Participation rate maps

Wellbeing services counties

Latest year (2024)

Municipalities

Latest year (2024)

Age group screening

Cancer detection mode

Cancers in Cancer Registry (2020-2024)

Cancer detection mode	N	Of all cancers (%)	Of cancers in screening age (%)
Screened cancer	356	30.1	39.1
Interval cancer	175	14.8	19.2
Unattended	345	29.1	37.9
Not invited	35	3.0	3.8
Younger than screening age	25	2.1	--
Older than screening age	248	20.9	--
Total	1184	100.0	100.0

Details

Data

• The data includes all persons eligible for screening, and the screening-chain related findings reported on them by spring 2026.
• Only screening registry data has been used in the classification of findings, i.e. the figures do not include cancer findings outside the screening programme that are later linked from the cancer registry. Cancer registry data has also been utilised in the detection-mode-specific classifications.

Indicator definitions

• The participation rate was calculated by dividing the successful tests (at most one per person) with the number of persons who were invited. Since 2020, due to limitations in registration, the number of persons invited might be slightly smaller/larger than reported here.
  
• Screening results are classified as the most severe result of the person within a screening episode.
  
• The confidence intervals in positivity rates and attendance rates model the uncertainty related to size of the population and random variation. The intervals are calculated using exact binomial model and 95% confidence.

Population classification

• The statistics production uses Statistics Finland’s individual-level data on education under permit TK/2743/07.03.00/2023.
  
• Education categories were created by combining the categories of pre-primary, lower primary, and upper primary education into the primary education category, combining secondary education and special vocational qualifications into the secondary education category, and combining lower and upper tertiary education and doctoral education into the tertiary education category. Unknown and missing data were combined with the primary education category. The education data is from the year preceding the screening year (e.g. for screening year 2024, the education data is from 2023).
  
• Native language and area of birth are based on data from the Digital and Population Data Services Agency.

Result classification

• Normal: The next invitation will be sent after 5 years until age 65.
  
• Borderline: The result requires a follow-up screen (new sample) after 18-24 months (HPV+, ASC-US, LSIL with no referral).
  
• Referral: The result requires a referral to colposcopy or a referral has been given.
  
• HPV tested: The number and proportion of women screened by the HPV test of the screened women. Overlaps with the other result categories.
  
• HPV positive: The number and proportion of HPV positives of women who were screened by the HPV test. Overlaps with the other result categories.
  
• Cervical cancer: Invasive and microinvasive carsinomas of the cervix.
  
• AIS: Adenocarcinoma in situ.
  
• HSIL: Histological HSIL, high-grade squamous intraepithelial lesion.
  
• LSIL: Histological LSIL, low-grade squamous intraepithelial lesion.
  
• Normal/benign: Normal or benign findings.
  
• No further examinations: The person did not attend colposcopy or data has not been delivered to the cancer registry.
  
• Other/unknown: Result is missing/inadequate; No biopsy was taken; Other cancers or precancers (primary site other than cervix).
• Histological HSIL+: HSIL, AIS, or cervical cancer.
• Colposcopy done: The person attended colposcopy and data was delivered to the cancer registry. This information has been available since around 2022.

Cancer detection mode

• The cancer detection mode categories are defined as follows, taking into account both age- and risk-group screening:
  • Screened cancer: In the preceding screen within one year before the diagnosis, a referral to further examinations was made and a biopsy was taken.
  • Interval cancer:
    • In the preceding screen within 5.5 years before the diagnosis, no referral to further examinations was made and no biopsy was taken.
    • In the preceding screen within 5.5 years before the diagnosis, a referral to further examinations was made and a biopsy was taken, but the date of diagnosis is 1–5.5 years after the screening test.
  • Unattended: Invited to screening within 5.5 years before the diagnosis, but did not attend.
  • Not invited: In screening age, but no registered invitation within 5.5 years before the diagnosis.
  • Younger than screening age: Diagnosis received before screening age.
  • Older than screening age: Diagnosis received more than 5.5 years after passing screening age.